Curable composition, method for producing pixel, film, optical filter, solid-state imaging element, and image display device

The curable composition with a specific ratio of E-form and Z-form photopolymerization initiator addresses exposure margin and storage stability issues in pixel formation, resulting in stable and defect-free film formation.

WO2024237133A1PCT designated stage expired Publication Date: 2024-11-21FUJIFILM CORP
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
PCT/JP2024/016965
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-18
Filing Date
2024-05-07
Publication Date
2024-11-21

AI Technical Summary

Technical Problem

The existing curable compositions using oxime ester compounds for pixel formation in photolithography suffer from fluctuations in line width due to exposure variations and have poor storage stability, leading to foreign matter defects in films.

Method used

A curable composition is developed containing a specific ratio of E-form and Z-form of a photopolymerization initiator, which reduces crystallinity and enhances storage stability, allowing for uniform curing and reduced foreign matter defects, while providing a large exposure margin.

Benefits of technology

The composition achieves stable film formation with suppressed line width variations and foreign matter defects, ensuring uniform curing and improved storage stability.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure JP2024016965_21112024_PF_FP_ABST
    Figure JP2024016965_21112024_PF_FP_ABST
Patent Text Reader

Abstract

This curable composition contains a photoinitiator and a radical polymerizable compound. The photoinitiator contains a body E of a compound represented by formula (1) and a body Z of a compound represented by formula (1), and the content of the body E with respect to the total mass of the body E and the body Z is 80-99.9 mass %. Also provided are a method for manufacturing a pixel using the curable composition, a film, an optical filter, a solid-state imaging element, and an image display device.
Need to check novelty before this filing date? Find Prior Art

Description

Curable composition, pixel manufacturing method, film, optical filter, solid-state imaging device and image display device

[0001] The present invention relates to a curable composition containing a photopolymerization initiator and a radically polymerizable compound. The present invention also relates to a pixel manufacturing method, a film, an optical filter, a solid-state imaging device, and an image display device using the curable composition.

[0002] Curable compositions containing a photopolymerization initiator and a radically polymerizable compound can be polymerized and cured by irradiation with light, and are therefore used in optical filters, photocurable inks, photosensitive printing plates, various photoresists, and the like.

[0003] Patent Document 1 discloses a curable composition using an oxime ester compound having a specific structure as a photopolymerization initiator.

[0004] International Publication No. 2015 / 152153

[0005] The present inventors have conducted extensive research into a curable composition using the oxime ester compound disclosed in Patent Document 1, and have found that when pixels are formed by photolithography using this curable composition, fluctuations in the exposure dose tend to cause variations in the line width of the resulting pixels, and that there is room for further improvement in the exposure margin.

[0006] Furthermore, according to the investigations of the present inventors, it has been found that the oxime ester compound disclosed in Patent Document 1 is highly crystalline, and that a curable composition using this oxime ester compound generates foreign matter during storage, which tends to cause foreign matter defects in the resulting film.

[0007] Therefore, an object of the present invention is to provide a curable composition having a large exposure margin and excellent storage stability. Also, an object of the present invention is to provide a method for producing a pixel, a film, an optical filter, a solid-state imaging device, and an image display device.

[0008] The present inventors have conducted research and found that the above object can be achieved by using a curable composition described below, and have thus completed the present invention.

[0009] <1> A curable composition comprising a photopolymerization initiator and a radically polymerizable compound, wherein the photopolymerization initiator comprises an E-isomer of a compound represented by formula (1) and a Z-isomer of a compound represented by formula (1), and the content of the E-isomer relative to the total mass of the E-isomer and the Z-isomer is 80 to 99.9 mass%; In formula (1), R 1 represents an alkyl group, an aryl group, a heteroaryl group, an alkoxy group, an aryloxy group, or a heteroaryloxy group; R 2 represents an alkyl group, an aryl group, or a heteroaryl group; R 3 ~R 7 each independently represents a hydrogen atom, a halogen atom, a nitro group, or a monovalent organic group; R 4 ~R 7 Adjacent groups among R may be bonded to form a ring, 101 represents a hydrogen atom or a monovalent organic group, n represents 0 or 1, and the wavy line represents a geometric isomer of E or Z. <2> R in the above formula (1) 101 represents a hydrogen atom, an alkyl group, or a group represented by formula (R-101); In formula (R-101), * represents a bond, 1 represents an aromatic ring group or a heterocyclic group; R 11 represents an alkyl group, an aryl group, a heteroaryl group, an alkoxy group, an alkylthio group, an alkylamino group, an aryloxy group, an arylthio group, an arylamino group, a heteroaryloxy group, a heteroarylthio group, a heteroarylamino group, a cyano group, a nitro group, a hydroxy group, a carboxy group, a halogen atom, or a group represented by formula (R-1), and m represents an integer of 0 to 5; In formula (R-1), Ar 2 represents an aromatic ring group or a heterocyclic group, 2The aromatic ring group or heterocyclic group represented by may have at least one substituent selected from an alkyl group, an aryl group, a heteroaryl group, an alkoxy group, an alkylthio group, an alkylamino group, an aryloxy group, an arylthio group, an arylamino group, a heteroaryloxy group, a heteroarylthio group, a heteroarylamino group, a cyano group, a nitro group, a hydroxy group, a carboxy group, a halogen atom, and an acyl group. 2 is a group represented by any one of formulas (Ar-1) to (Ar-17); In the formula, * represents a bond, a1 ~R a15 each independently represents an alkyl group, an aryl group, a heteroaryl group, an alkoxy group, an alkylthio group, an alkylamino group, an aryloxy group, an arylthio group, an arylamino group, a heteroaryloxy group, a heteroarylthio group, a heteroarylamino group, a cyano group, a nitro group, a hydroxy group, a carboxy group, a halogen atom, or an acyl group; R ar1 ~R ar9 each independently represents a hydrogen atom or a monovalent organic group, and k1 to k15 each independently represent an integer of 0 to 4. <4> R in the above formula (1) 2 The curable composition according to any one of <1> to <3>, wherein is a group represented by formula (R-2): In formula (R-2), * represents a bond, 21 represents a single bond or an alkylene group having 1 to 6 carbon atoms; R 21 and R 22 each independently represents an alkyl group having 1 to 4 carbon atoms; R 21 and R 21 may be bonded to each other to form a ring. 2 <1> <3> The curable composition according to any one of <1> to <3>, wherein is a group represented by formula (R-2a): In formula (R-2a), * represents a bond, 31 and R 32 each independently represents a hydrogen atom or a monovalent organic group; 31represents a single bond or an alkylene group having 1 to 6 carbon atoms; 32 is -(CR L1 R L2 ) p represents -, and R L1 and R L2 each independently represents a hydrogen atom or a monovalent organic group, and p represents an integer of 1 to 4. <6> The curable composition according to any one of <1> to <5>, which contains a colorant. <7> The curable composition according to any one of <1> to <6>, which contains a chain transfer agent. <8> The curable composition according to any one of <1> to <7>, which is for exposure to light having a wavelength of 150 nm to 300 nm. <9> A method for manufacturing a pixel, comprising the steps of: forming a curable composition layer on a support using the curable composition according to any one of <1> to <8>; irradiating the curable composition layer with light having a wavelength of 150 nm to 300 nm to perform patternwise exposure; and developing and removing the unexposed areas of the curable composition layer. <10> A film obtained by curing the curable composition according to any one of <1> to <8>. <11> An optical filter comprising the film according to <10>. <12> A solid-state imaging device comprising the film according to <10>. <13> An image display device comprising the film according to <10>.

[0010] According to the present invention, it is possible to provide a curable composition having a large exposure margin and excellent storage stability. The present invention also provides a method for producing a pixel, a film, an optical filter, a solid-state imaging device, and an image display device.

[0011] The present invention will be described in detail below. In this specification, the term "to" is used to mean that the numerical values ​​before and after the term are included as the lower and upper limits. In the description of groups (atomic groups) in this specification, a term without specifying whether it is substituted or unsubstituted encompasses both unsubstituted groups (atomic groups) and substituted groups (atomic groups). For example, the term "alkyl group" encompasses not only unsubstituted alkyl groups (unsubstituted alkyl groups) but also substituted alkyl groups (substituted alkyl groups). In this specification, unless otherwise specified, "exposure" includes not only exposure using light but also drawing using particle beams such as electron beams and ion beams. Examples of light used for exposure include the bright line spectrum of a mercury lamp, far ultraviolet light typified by excimer lasers, extreme ultraviolet light (EUV light), X-rays, electron beams, and other actinic rays or radiation. As used herein, "(meth)acrylate" refers to either or both of acrylate and methacrylate, "(meth)acrylic" refers to either or both of acrylic and methacrylic, and "(meth)acryloyl" refers to either or both of acryloyl and methacryloyl. In the structural formulae herein, Me refers to a methyl group, Et refers to an ethyl group, Bu refers to a butyl group, and Ph refers to a phenyl group. As used herein, the weight-average molecular weight and number-average molecular weight are polystyrene-equivalent values ​​measured by GPC (gel permeation chromatography). As used herein, the term "total solids" refers to the total mass of all components of a composition excluding the solvent. As used herein, the term "pigment" refers to a coloring material that is difficult to dissolve in a solvent. As used herein, the term "process" refers not only to an independent process, but also to a process that cannot be clearly distinguished from other processes, as long as the intended effect of the process is achieved.

[0012] <Curable composition> The curable composition of the present invention is a curable composition comprising a photopolymerization initiator and a radically polymerizable compound, wherein the photopolymerization initiator comprises an E-isomer of the compound represented by formula (1) and a Z-isomer of the compound represented by formula (1), and the content of the E-isomer relative to the total mass of the E-isomer and the Z-isomer is 80 to 99.9 mass%.

[0013] It is presumed that the curable composition of the present invention can reduce the crystallinity of the compound represented by formula (1) by using the E-isomer and the Z-isomer of the compound represented by formula (1) in combination in a predetermined ratio, and as a result, can suppress precipitation of the compound represented by formula (1) during storage of the curable composition. Therefore, the curable composition of the present invention has excellent storage stability, and can suppress the occurrence of foreign matter defects even when a film is formed using a curable composition that has been stored for a long period of time.

[0014] Furthermore, the curable composition of the present invention has a large exposure margin, and when pixels are formed by photolithography using the curable composition of the present invention, variations in the line width of the resulting pixels can be suppressed even if the exposure dose varies. The detailed reason for this effect is unknown, but it is presumed that this is because the E-isomer and the Z-isomer have very slight differences in sensitivity, and they mutually compensate for the process from light absorption to radical generation, making it easy to maintain a constant amount of radical generation even if the exposure dose varies.

[0015] The curable composition of the present invention preferably further contains a colorant. By using the E-isomer and Z-isomer of the compound represented by formula (1) in combination in a predetermined ratio, the curable composition of the present invention can reduce the crystallinity of the compound represented by formula (1) and allow the photopolymerization initiator to be dispersed almost uniformly in the curable composition. Therefore, during exposure, the curing reaction of the exposed area can proceed almost uniformly, and a film in which the colorant is dispersed almost uniformly can be formed. Therefore, a film with reduced color unevenness can be formed.

[0016] The curable composition containing a coloring material is preferably used as a curable composition for an optical filter. Examples of the optical filter include a color filter, a near-infrared transmission filter, and a near-infrared cut filter, and the color filter is preferred.

[0017] The color filter may have colored pixels that transmit light of a specific wavelength. Examples of the colored pixels include red, green, blue, magenta, cyan, and yellow pixels, with red pixels being more preferred. The colored pixels of the color filter may be formed using a curable composition containing a chromatic colorant.

[0018] The maximum absorption wavelength of the near-infrared cut filter is preferably in the wavelength range of 700 to 1800 nm, more preferably in the wavelength range of 700 to 1300 nm, and even more preferably in the wavelength range of 700 to 1000 nm. Furthermore, the transmittance of the near-infrared cut filter over the entire wavelength range of 400 to 650 nm is preferably 70% or more, more preferably 80% or more, and even more preferably 90% or more. Furthermore, the transmittance at at least one point in the wavelength range of 700 to 1800 nm is preferably 20% or less. Furthermore, the ratio of the absorbance Amax at the maximum absorption wavelength of the near-infrared cut filter to the absorbance A550 at a wavelength of 550 nm (absorbance Amax / absorbance A550) is preferably 20 to 500, more preferably 50 to 500, even more preferably 70 to 450, and particularly preferably 100 to 400. The near-infrared cut filter can be formed using a curable composition containing a near-infrared absorbing colorant.

[0019] The near-infrared transmission filter is a filter that transmits at least a portion of near-infrared light. The near-infrared transmission filter is preferably a filter that blocks at least a portion of visible light and transmits at least a portion of near-infrared light. Examples of near-infrared transmission filters include filters that satisfy the spectral characteristics of a maximum transmittance of 20% or less (preferably 15% or less, more preferably 10% or less) in the wavelength range of 400 to 640 nm and a minimum transmittance of 70% or more (preferably 75% or more, more preferably 80% or more) in the wavelength range of 1100 to 1300 nm. The near-infrared transmission filter is preferably a filter that satisfies any one of the following spectral characteristics (1) to (5): (1): A filter that has a maximum transmittance of 20% or less (preferably 15% or less, more preferably 10% or less) in the wavelength range of 400 to 640 nm and a minimum transmittance of 70% or more (preferably 75% or more, more preferably 80% or more) in the wavelength range of 800 to 1500 nm. (2): A filter having a maximum transmittance of 20% or less (preferably 15% or less, more preferably 10% or less) in the wavelength range of 400 to 750 nm, and a minimum transmittance of 70% or more (preferably 75% or more, more preferably 80% or more) in the wavelength range of 900 to 1500 nm. (3): A filter having a maximum transmittance of 20% or less (preferably 15% or less, more preferably 10% or less) in the wavelength range of 400 to 830 nm, and a minimum transmittance of 70% or more (preferably 75% or more, more preferably 80% or more) in the wavelength range of 1000 to 1500 nm. (4): A filter having a maximum transmittance of 20% or less (preferably 15% or less, more preferably 10% or less) in the wavelength range of 400 to 950 nm, and a minimum transmittance of 70% or more (preferably 75% or more, more preferably 80% or more) in the wavelength range of 1100 to 1500 nm. (5): A filter having a maximum transmittance of 20% or less (preferably 15% or less, more preferably 10% or less) in the wavelength range of 400 to 1050 nm, and a minimum transmittance of 70% or more (preferably 75% or more, more preferably 80% or more) in the wavelength range of 1200 to 1500 nm.

[0020] The curable composition of the present invention can also be used as a light-shielding film.

[0021] The solids concentration of the curable composition of the present invention is preferably 5 to 30% by mass. The lower limit is preferably 7.5% by mass or more, more preferably 10% by mass or more. The upper limit is preferably 25% by mass or less, more preferably 20% by mass or less, and even more preferably 15% by mass or less.

[0022] The curable composition of the present invention exhibits a particularly high exposure margin when exposed to light with a wavelength of 150 to 300 nm. Therefore, the curable composition of the present invention is preferably used as a curable composition for exposure to light with a wavelength of 150 to 300 nm. Examples of light with a wavelength of 150 to 300 nm include KrF radiation (wavelength 248 nm) and ArF radiation (wavelength 193 nm), with KrF radiation (wavelength 248 nm) being preferred. The light with a wavelength of 150 to 300 nm is preferably excimer laser light with a wavelength of 150 to 300 nm.

[0023] Each component used in the curable composition of the present invention will be described below.

[0024] <<Photopolymerization Initiator>> The curable composition of the present invention contains a photopolymerization initiator. The photopolymerization initiator is preferably a photoradical polymerization initiator.

[0025] (Specific Oxime Ester Compound) In the curable composition of the present invention, a photopolymerization initiator containing an E-isomer of a compound represented by formula (1) and a Z-isomer of a compound represented by formula (1) is used. Hereinafter, the E-isomer of a compound represented by formula (1) will also be referred to as specific oxime ester compound (E), and the Z-isomer of a compound represented by formula (1) will also be referred to as specific oxime ester compound (Z). In addition, the E-isomer of a compound represented by formula (1) and the Z-isomer of a compound represented by formula (1) will collectively be referred to as specific oxime ester compounds. In formula (1), R 1 represents an alkyl group, an aryl group, a heteroaryl group, an alkoxy group, an aryloxy group, or a heteroaryloxy group; R 2 represents an alkyl group, an aryl group, or a heteroaryl group; R 3 ~R7 each independently represents a hydrogen atom, a halogen atom, a nitro group, or a monovalent organic group; R 4 ~R 7 Adjacent groups among R may be bonded to form a ring, 101 represents a hydrogen atom or a monovalent organic group, n represents 0 or 1, and the wavy line represents an E- or Z-geometric isomer.

[0026] In formula (1), n ​​represents 0 or 1, and is preferably 0 because this allows for increased sensitivity when exposed to light having a wavelength of 150 nm to 300 nm, such as KrF radiation.

[0027] R in formula (1) 1 represents an alkyl group, an aryl group, a heteroaryl group, an alkoxy group, an aryloxy group, or a heteroaryloxy group, and is preferably an alkyl group or an aryl group, and more preferably an alkyl group.

[0028] R 1 The number of carbon atoms in the alkyl group represented by is preferably 1 to 15, more preferably 1 to 10, even more preferably 1 to 5, and even more preferably 1 to 3. The alkyl group may be linear, branched, or cyclic, but is preferably linear or branched, and more preferably linear. The alkyl group may have a substituent, but is preferably an unsubstituted alkyl group. R 1 The alkyl group represented by is preferably an unsubstituted linear or branched alkyl group, and more preferably an unsubstituted linear alkyl group.

[0029] R 1 The number of carbon atoms in the alkoxy group represented by is preferably 1 to 15, more preferably 1 to 10, even more preferably 1 to 5, and even more preferably 1 to 3. The alkoxy group is preferably linear or branched, more preferably linear. The alkoxy group may have a substituent, but is preferably unsubstituted.

[0030] R 1The number of carbon atoms in the aryl group and aryloxy group represented by the formula (I) is preferably 6 to 20, more preferably 6 to 12, still more preferably 6 to 10, and particularly preferably 6. The aryl group and aryloxy group may have a substituent, but are preferably unsubstituted.

[0031] R 1 The heteroaryl group and heteroaryloxy group represented by the formula (I) preferably have 1 to 15 carbon atoms constituting the ring, and more preferably 1 to 10. The types of heteroatoms constituting the ring of the heteroaryl group and heteroaryloxy group include a nitrogen atom, an oxygen atom, and a sulfur atom. The number of heteroatoms constituting the ring of the heteroaryl group and heteroaryloxy group is preferably 1 to 3, and more preferably 1 or 2. The heteroaryl group and heteroaryloxy group may be a monocyclic ring or a fused ring. The heteroaryl group and heteroaryloxy group may have a substituent.

[0032] R in formula (1) 2 represents an alkyl group, an aryl group or a heteroaryl group, and is preferably an alkyl group.

[0033] R 2 The number of carbon atoms in the alkyl group represented by is preferably 1 to 15, and more preferably 1 to 10. The alkyl group may be linear, branched, or cyclic, but is preferably branched or cyclic. The alkyl group may have a substituent. Examples of the substituent include an alkenyl group, an aryl group, a heteroaryl group, an alkoxy group, an alkylthio group, an alkylamino group, an aryloxy group, an arylthio group, an arylamino group, a heteroaryloxy group, a heteroarylthio group, a heteroarylamino group, a cyano group, a nitro group, a hydroxy group, a carboxy group, and a halogen atom.

[0034] R 2The number of carbon atoms in the aryl group represented by is preferably 6 to 20, more preferably 6 to 12, still more preferably 6 to 10, and particularly preferably 6. The aryl group may have a substituent. Examples of the substituent include an alkyl group, an alkenyl group, a heteroaryl group, an alkoxy group, an alkylthio group, an alkylamino group, an aryloxy group, an arylthio group, an arylamino group, a heteroaryloxy group, a heteroarylthio group, a heteroarylamino group, a cyano group, a nitro group, a hydroxy group, a carboxy group, and a halogen atom.

[0035] R 2 The number of carbon atoms constituting the ring of the heteroaryl group represented by is preferably 1 to 15, more preferably 1 to 10. Examples of heteroatoms constituting the ring of the heteroaryl group include nitrogen atoms, oxygen atoms, and sulfur atoms. The number of heteroatoms constituting the ring of the heteroaryl group is preferably 1 to 3, more preferably 1 to 2. The heteroaryl group may be a monocyclic ring or a fused ring. The heteroaryl group and the heteroaryloxy group may have a substituent. Examples of the substituent include an alkyl group, an alkenyl group, an aryl group, an alkoxy group, an alkylthio group, an alkylamino group, an aryloxy group, an arylthio group, an arylamino group, a heteroaryloxy group, a heteroarylthio group, a heteroarylamino group, a cyano group, a nitro group, a hydroxy group, a carboxy group, and a halogen atom.

[0036] R in formula (1) 2 is R 2 is preferably a group represented by formula (R-2). In formula (R-2), * represents a bond, 21 represents a single bond or an alkylene group having 1 to 6 carbon atoms; R 21 and R 22 each independently represents an alkyl group having 1 to 4 carbon atoms; R 21 and R 21 may be bonded to each other to form a ring.

[0037] L in formula (R-2) 21represents a single bond or an alkylene group having 1 to 6 carbon atoms, and preferably an alkylene group having 1 to 6 carbon atoms. The alkylene group preferably has 1 to 4 carbon atoms, more preferably 1 to 3 carbon atoms, and even more preferably 1 or 2 carbon atoms.

[0038] In formula (R-2), R 21 and R 21 The ring formed by bonding together is preferably a 3- to 6-membered ring, more preferably a 5- or 6-membered ring, and even more preferably a 5-membered ring.

[0039] R in formula (1) 2 is particularly preferably a group represented by formula (R-2a). In formula (R-2a), * represents a bond, 31 and R 32 each independently represents a hydrogen atom or a monovalent organic group; 31 represents a single bond or an alkylene group having 1 to 6 carbon atoms; 32 is -(CR L1 R L2 ) p represents -, and R L1 and R L2 each independently represents a hydrogen atom or a monovalent organic group, and p represents an integer of 1 to 4.

[0040] L in formula (R-2a) 31 represents a single bond or an alkylene group having 1 to 6 carbon atoms, and preferably an alkylene group having 1 to 6 carbon atoms. The alkylene group preferably has 1 to 4 carbon atoms, more preferably 1 to 3 carbon atoms, and even more preferably 1 or 2 carbon atoms.

[0041] R in formula (R-2a) 31 , R 32 , R L1 and R L2 Examples of the monovalent organic group represented by R in formula (R-2a) include an alkyl group and an aryl group. 31 , R 32 , R L1 and R L2is preferably a hydrogen atom. p represents an integer of 1 to 4, preferably 3 or 4, and more preferably 3.

[0042] R in formula (1) 3 ~R 7 R each independently represents a hydrogen atom, a halogen atom, a nitro group, or a monovalent organic group. 3 ~R 7 Examples of the monovalent organic group represented by R include an alkyl group, an alkenyl group, and an aryl group. 4 ~R 7 Adjacent groups among R in formula (1) may be bonded to each other to form a ring. The formed ring is preferably a 5-membered ring or a 6-membered ring. 3 ~R 7 is preferably a hydrogen atom.

[0043] R in formula (1) 101 represents a hydrogen atom or a monovalent organic group, preferably a monovalent organic group. Examples of the monovalent organic group include an alkyl group, an aryl group, and a group represented by formula (R-101), preferably a group represented by formula (R-101).

[0044] The number of carbon atoms in the alkyl group is preferably 1 to 15, and more preferably 1 to 10. The alkyl group may be linear, branched, or cyclic, but is preferably branched or cyclic. The alkyl group may have a substituent. Examples of the substituent include an alkenyl group, an aryl group, a heteroaryl group, an alkoxy group, an alkylthio group, an alkylamino group, an aryloxy group, an arylthio group, an arylamino group, a heteroaryloxy group, a heteroarylthio group, a heteroarylamino group, a cyano group, a nitro group, a hydroxy group, a carboxy group, and a halogen atom.

[0045] The number of carbon atoms in the aryl group is preferably 6 to 20, more preferably 6 to 12, still more preferably 6 to 10, and particularly preferably 6. The aryl group may have a substituent. Examples of the substituent include an alkyl group, an alkenyl group, a heteroaryl group, an alkoxy group, an alkylthio group, an alkylamino group, an aryloxy group, an arylthio group, an arylamino group, a heteroaryloxy group, a heteroarylthio group, a heteroarylamino group, a cyano group, a nitro group, a hydroxy group, a carboxy group, and a halogen atom.

[0046] In formula (R-101), * represents a bond, 1 represents an aromatic ring group or a heterocyclic group; R 11 represents an alkyl group, an aryl group, a heteroaryl group, an alkoxy group, an alkylthio group, an alkylamino group, an aryloxy group, an arylthio group, an arylamino group, a heteroaryloxy group, a heteroarylthio group, a heteroarylamino group, a cyano group, a nitro group, a hydroxy group, a carboxy group, a halogen atom, or a group represented by formula (R-1), and m represents an integer of 0 to 5; In formula (R-1), Ar 2 represents an aromatic ring group or a heterocyclic group; 2 The aromatic ring group or heterocyclic group represented by may have at least one substituent selected from an alkyl group, an aryl group, a heteroaryl group, an alkoxy group, an alkylthio group, an alkylamino group, an aryloxy group, an arylthio group, an arylamino group, a heteroaryloxy group, a heteroarylthio group, a heteroarylamino group, a cyano group, a nitro group, a hydroxy group, a carboxy group, a halogen atom, and an acyl group.

[0047] Ar in formula (R-101) 1 The aromatic ring group represented by the formula (I) preferably has 6 to 20 carbon atoms, more preferably 6 to 12 carbon atoms, even more preferably 6 to 10 carbon atoms, and particularly preferably 6 carbon atoms.

[0048] Ar in formula (R-101) 1The heterocyclic group represented by is preferably a 5-membered or 6-membered ring. The heteroatom contained in the heterocyclic group is preferably an oxygen atom, a nitrogen atom, or a sulfur atom. The number of heteroatoms contained in the heterocyclic group is preferably 1 to 3. The heterocyclic group may be a monocyclic ring or a condensed ring.

[0049] R in formula (R-101) 11 represents an alkyl group, an aryl group, a heteroaryl group, an alkoxy group, an alkylthio group, an alkylamino group, an aryloxy group, an arylthio group, an arylamino group, a heteroaryloxy group, a heteroarylthio group, a heteroarylamino group, a cyano group, a nitro group, a hydroxy group, a carboxy group, a halogen atom, or a group represented by formula (R-1), preferably an alkyl group, an alkoxy group, a cyano group, a nitro group, a carboxy group, a halogen atom, or a group represented by formula (R-1), more preferably a group represented by formula (R-1).

[0050] m represents an integer of 0 to 5, preferably an integer of 1 to 5, more preferably 1 or 2, and even more preferably 1. When m is 2 or more, m R 11 At least one of the groups is preferably a group represented by formula (R-1).

[0051] R in formula (R-101) 11 The group represented by formula (R-1) will be explained.

[0052] Ar in formula (R-1) 2 represents an aromatic ring group or a heterocyclic group. 2 The aromatic ring group represented by is preferably 6 to 20 carbon atoms, more preferably 6 to 12 carbon atoms, even more preferably 6 to 10 carbon atoms, and particularly preferably 6 carbon atoms. 2 The heterocyclic group represented by is preferably a 5-membered or 6-membered ring. The heteroatom contained in the heterocyclic group is preferably an oxygen atom, a nitrogen atom, or a sulfur atom. The number of heteroatoms contained in the heterocyclic group is preferably 1 to 3. The heterocyclic group may be a monocyclic ring or a condensed ring.

[0053] Ar 2The aromatic ring group or heterocyclic group represented by may have at least one substituent selected from an alkyl group, an aryl group, a heteroaryl group, an alkoxy group, an alkylthio group, an alkylamino group, an aryloxy group, an arylthio group, an arylamino group, a heteroaryloxy group, a heteroarylthio group, a heteroarylamino group, a cyano group, a nitro group, a hydroxy group, a carboxy group, a halogen atom, and an acyl group.

[0054] Ar in formula (R-1) 2 is preferably a group represented by any one of formulas (Ar-1) to (Ar-17), and more preferably a group represented by any one of formulas (Ar-1), (Ar-2), (Ar-4), (Ar-6), (Ar-8) and (Ar-15).

[0055] In the formula, * represents a bond, a1 ~R a15 each independently represents an alkyl group, an aryl group, a heteroaryl group, an alkoxy group, an alkylthio group, an alkylamino group, an aryloxy group, an arylthio group, an arylamino group, a heteroaryloxy group, a heteroarylthio group, a heteroarylamino group, a cyano group, a nitro group, a hydroxy group, a carboxy group, a halogen atom, or an acyl group; R ar1 ~R ar9 each independently represents a hydrogen atom or a monovalent organic group; and k1 to k15 each independently represent an integer of 0 to 4.

[0056] R ar1 ~R ar9 Examples of the monovalent organic group represented by R include an alkyl group, an aryl group, and a heteroaryl group. ar1 ~R ar9 The monovalent organic group represented by may have a substituent, such as an alkoxy group, an alkylthio group, an alkylamino group, an aryloxy group, an arylthio group, an arylamino group, a heteroaryloxy group, a heteroarylthio group, a heteroarylamino group, a cyano group, a nitro group, a hydroxy group, a carboxy group, a halogen atom, and an acyl group.

[0057] In this specification, the E-form of the compound represented by formula (1) (specific oxime ester compound (E)) means the compound represented by formula (1E), and the Z-form of the compound represented by formula (1) (specific oxime ester compound (Z)) means the compound represented by formula (1Z). The compound represented by formula (1E) is a compound having an E-form conformation, and the compound represented by formula (1Z) is a compound having a Z-form conformation.

[0058] In the photopolymerization initiator used in the curable composition of the present invention, the content of the specific oxime ester compound (E) relative to the total mass of the specific oxime ester compound (E) and the specific oxime ester compound (Z) is 80 to 99.9 mass%, preferably 85 to 99.9 mass%, more preferably 90 to 99.9 mass%, because this enables further enhancement of sensitivity when exposed to light having a wavelength of 150 nm to 300 nm, such as KrF radiation.

[0059] When the compound represented by formula (1) is synthesized, the obtained compound may be a mixture of the specific oxime ester compound (E) and the specific oxime ester compound (Z). However, by adjusting the synthesis conditions, the ratio of the specific oxime ester compound (E) to the specific oxime ester compound (Z) can be adjusted.

[0060] Furthermore, when the compound obtained by synthesis is a mixture of the specific oxime ester compound (E) and the specific oxime ester compound (Z), the specific oxime ester compound (E) and the specific oxime ester compound (Z) can be individually isolated by purifying the mixture by a method such as silica gel column chromatography. By adjusting the mixing ratio of the isolated specific oxime ester compound (E) and the specific oxime ester compound (Z), the content of the specific oxime ester compound (E) relative to the total mass of the specific oxime ester compound (E) and the specific oxime ester compound (Z) can be adjusted.

[0061] The ratio of the specific oxime ester compound (E) to the specific oxime ester compound (Z) can be confirmed by a method such as nuclear magnetic resonance analysis (NMR) or high performance liquid chromatography (HPLC).

[0062] The compound of formula (1) where n is 0 (specific oxime ester compound (1a)) can be synthesized, for example, according to the following synthesis scheme.

[0063] An oxime compound (a-2) is obtained by subjecting an indole ketone compound (a-1) to an addition reaction with an oximation agent such as hydroxylamine hydrochloride in the presence of a base. The obtained oxime compound (a-2) is a mixture of E- and Z-isomers, which are geometric isomers. The ratio of the E- and Z-isomers (hereinafter also referred to as the E / Z ratio) can be adjusted by changing the synthesis conditions for the oxime compound (a-2), such as the reaction temperature, light (ultraviolet light), solvent, base, and type of oximation agent. The obtained oxime compound (a-2) is esterified with an esterifying agent to obtain a specific oxime ester compound (1a). The obtained oxime ester compound (1a) is a mixture of E- and Z-isomers, which are geometric isomers. The above esterification reaction proceeds while substantially maintaining the E / Z ratio of the oxime compound (a-2), and therefore the E / Z ratio of the obtained specific oxime ester compound (1a) is substantially the same as the E / Z ratio of the oxime compound (a-2). The resulting specific oxime ester compound (1a) can be purified by a method such as silica gel column chromatography to isolate the E-form and the Z-form.

[0064] The compound of formula (1) where n is 1 (specific oxime ester compound (1b)) can be synthesized, for example, according to the following synthesis scheme.

[0065] An oxime compound (b-2) is obtained by oximating the α-position of the ketone by addition reaction of an indole ketone compound (b-1) with an oximation agent such as an alkyl nitrite in the presence of an acid or a base. The obtained oxime compound (b-2) is a mixture of geometric isomers, E- and Z-isomers. The ratio of the E- and Z-isomers (E / Z ratio) can be adjusted by changing the synthesis conditions for the oxime compound (b-2), such as the reaction temperature, light (ultraviolet light), solvent, base, and type of oximation agent. The obtained oxime compound (b-2) is esterified with an esterification agent to obtain a specific oxime ester compound (1b). The obtained oxime ester compound (1b) is a mixture of geometric isomers, E- and Z-isomers. The esterification proceeds while the E / Z ratio of the oxime compound (b-2) is substantially maintained, and therefore the E / Z ratio of the resulting specific oxime ester compound (1b) is substantially the same as that of the oxime compound (b-2). The resulting specific oxime ester compound (1b) can be purified by a method such as silica gel column chromatography to isolate the E-isomer and the Z-isomer.

[0066] Specific examples of the specific oxime ester compound include the compounds shown below: In the structural formula shown below, the wavy line represents a geometric isomer of Z or E isomer.

[0067] (Other Photopolymerization Initiators) The curable composition of the present invention may further contain a photopolymerization initiator other than the specific oxime ester compound described above (hereinafter also referred to as other photopolymerization initiator). The combined use of the specific oxime ester compound described above and the other photopolymerization initiator provides the effects of improving pattern rectangularity and pattern adhesion. When the specific oxime ester compound described above and the other photopolymerization initiator are used in combination, the content of the other photopolymerization initiator is preferably 1 to 100 parts by mass per 100 parts by mass of the specific oxime ester compound. The upper limit is preferably 80 parts by mass or less, more preferably 50 parts by mass or less. The lower limit is preferably 5 parts by mass or more, more preferably 10 parts by mass or more, and even more preferably 20 parts by mass or more.

[0068] Examples of the other photopolymerization initiator include halogenated hydrocarbon derivatives (e.g., compounds having a triazine skeleton, compounds having an oxadiazole skeleton, etc.), acylphosphine compounds, hexaarylbiimidazole compounds, oxime compounds, organic peroxides, thio compounds, ketone compounds, aromatic onium salts, α-hydroxyketone compounds, α-aminoketone compounds, etc. The other photopolymerization initiator is preferably a trihalomethyltriazine compound, a benzyl dimethyl ketal compound, an α-hydroxyketone compound, an α-aminoketone compound, an acylphosphine compound, a phosphine oxide compound, a metallocene compound, an oxime compound, a hexaarylbiimidazole compound, an onium compound, a benzothiazole compound, a benzophenone compound, an acetophenone compound, a cyclopentadiene-benzene-iron complex, a halomethyloxadiazole compound, or a 3-aryl-substituted coumarin compound, more preferably an oxime compound, an α-hydroxyketone compound, an α-aminoketone compound, or an acylphosphine compound, and even more preferably an oxime compound.Other photopolymerization initiators include compounds described in paragraphs 0065 to 0111 of JP-A-2014-130173, compounds described in Japanese Patent No. 6301489, peroxide-based photopolymerization initiators described in MATERIAL STAGE 37 to 60p, vol. 19, No. 3, 2019, photopolymerization initiators described in WO 2018 / 221177, photopolymerization initiators described in WO 2018 / 110179, photopolymerization initiators described in JP-A-2019-043864, photopolymerization initiators described in JP-A-2019-044030, peroxide-based initiators described in JP-A-2019-167313, and oxazolidinyl compounds described in JP-A-2020-055992. Aminoacetophenone initiators having an amine group, oxime photopolymerization initiators described in JP 2013-190459 A, polymers described in JP 2020-172619 A, compounds represented by formula 1 described in WO 2020 / 152120 A, compounds described in JP 2021-181406 A, photopolymerization initiators described in JP 2022-013379 A, ​​compounds represented by formula (1) described in JP 2022-015747 A compounds described in Taiwan Patent Application Publication No. 202200534; compounds described in JP 2022-078550; compounds described in Korean Patent Publication No. 10-2017; compounds described in JP 2021-507058 A; initiators described in Chinese Patent Application Publication No. 110764367; initiators described in Japanese Patent Application Publication No. 2022-518535; initiators described in WO 2021 / 175855; compounds described in Taiwan Patent Application Publication No. 202200534; compounds described in Japanese Patent Application Publication No. 2022-078550; -0087330, compounds described in WO 2022 / 075452, oxime ester compounds described in Chinese Patent Application Publication No. 110066225, compounds described in Korean Patent Publication No. 10-2022-0076157, and compounds having a triarylamine or N-arylcarbazole skeleton described in paragraphs 0042 to 0062 of WO 2019 / 013112.

[0069] Specific examples of the hexaarylbiimidazole compound include 2,2',4-tris(2-chlorophenyl)-5-(3,4-dimethoxyphenyl)-4,5-diphenyl-1,1'-biimidazole.

[0070] Commercially available α-hydroxyketone compounds include Omnirad 184, Omnirad 1173, Omnirad 2959, and Omnirad 127 (all manufactured by IGM Resins B.V.), and Irgacure 184, Irgacure 1173, Irgacure 2959, and Irgacure 127 (all manufactured by BASF). Commercially available α-aminoketone compounds include Omnirad 907, Omnirad 369, Omnirad 369E, Omnirad 379EG (all manufactured by IGM Resins B.V.), Irgacure 907, Irgacure 369, Irgacure 369E, Irgacure 379EG (all manufactured by BASF), etc. Commercially available acylphosphine compounds include Omnirad 819, Omnirad TPO (all manufactured by IGM Resins B.V.), Irgacure 819, Irgacure TPO (all manufactured by BASF), etc.

[0071] Examples of the oxime compound include the compounds described in paragraph 0142 of WO 2022 / 085485, the compounds described in Japanese Patent No. 5430746, the compounds described in Japanese Patent No. 5647738, the compounds represented by the general formula (1) of JP-A-2021-173858, and the compounds described in paragraphs 0022 to 0024, and the compounds represented by the general formula (1) of JP-A-2021-170089 and the compounds described in paragraphs 0117 to 0120. Specific examples of the oxime compound include 3-benzoyloxyiminobutan-2-one, 3-acetoxyiminobutan-2-one, 3-propionyloxyiminobutan-2-one, 2-acetoxyiminopentan-3-one, 2-acetoxyimino-1-phenylpropan-1-one, 2-benzoyloxyimino-1-phenylpropan-1-one, 3-(4-toluenesulfonyloxy)iminobutan-2-one, 2-ethoxycarbonyloxyimino-1-phenylpropan-1-one, 1-[4-(phenylthio)phenyl]-3-cyclohexyl-propane-1,2-dione-2-(O-acetyloxime), and the like. Commercially available products include Irgacure OXE01, Irgacure OXE02, Irgacure OXE03, and Irgacure OXE04 (all manufactured by BASF), and Adeka Optomer N-1919 (manufactured by ADEKA Corporation; photopolymerization initiator 2 described in JP 2012-014052 A). As the oxime compound, it is also preferable to use a compound that is not colorable or a compound that is highly transparent and does not easily discolor. Commercially available products include Adeka Arcles NCI-730, NCI-831, and NCI-930 (all manufactured by ADEKA Corporation).

[0072] Other photopolymerization initiators that can be used include oxime compounds having a fluorene ring, oxime compounds having a skeleton in which at least one benzene ring of a carbazole ring is replaced with a naphthalene ring, oxime compounds having a fluorine atom, oxime compounds having a nitro group, oxime compounds having a benzofuran skeleton, oxime compounds in which a substituent having a hydroxy group is bonded to a carbazole skeleton, and the compounds described in paragraphs 0143 to 0149 of WO 2022 / 085485.

[0073] As the other photopolymerization initiator, a bifunctional or trifunctional or higher functional photopolymerization initiator may be used. Specific examples of the bifunctional or trifunctional or higher functional photopolymerization initiator include the compounds described in paragraph 0148 of WO 2022 / 065215.

[0074] The content of the photopolymerization initiator in the total solid content of the curable composition is preferably 1 to 20% by mass. The lower limit is preferably 1.5% by mass or more, and more preferably 2% by mass or more. The upper limit is preferably 15% by mass or less, more preferably 10% by mass or less, and even more preferably 8% by mass or less.

[0075] The total content of the specific oxime ester compound (E) and the specific oxime ester compound (Z) in the total solid content of the curable composition is preferably 1 to 20% by mass. The lower limit is preferably 1.5% by mass or more, more preferably 2% by mass or more. The upper limit is preferably 15% by mass or less, more preferably 10% by mass or less, and even more preferably 8% by mass or less.

[0076] The total content of the specific oxime ester compound (E) and the specific oxime ester compound (Z) in the photopolymerization initiator used in the curable composition of the present invention is preferably 50 to 100% by mass, more preferably 80 to 100% by mass, and even more preferably 90 to 100% by mass. It is also preferable that the photopolymerization initiator used in the curable composition of the present invention consists essentially of the specific oxime ester compound (E) and the specific oxime ester compound (Z). This embodiment more significantly exhibits the effects of the present invention. In this specification, when the photopolymerization initiator consists essentially of the specific oxime ester compound (E) and the specific oxime ester compound (Z), this means that the total content of the specific oxime ester compound (E) and the specific oxime ester compound (Z) in the photopolymerization initiator is 99% by mass or more, preferably 99.9% by mass or more, and more preferably the specific oxime ester compound (E) and the specific oxime ester compound (Z) alone.

[0077] In the curable composition of the present invention, the photopolymerization initiator may be used alone or in combination with two or more types. When two or more types are used, the total amount thereof is preferably within the above range.

[0078] <<Radical Polymerizable Compound>> The curable composition of the present invention contains a radical polymerizable compound. Examples of the radical polymerizable compound include a compound having an ethylenically unsaturated bond-containing group. Examples of the ethylenically unsaturated bond-containing group include a vinyl group, a (meth)allyl group, and a (meth)acryloyl group.

[0079] The radical polymerizable compound may be in any chemical form such as a monomer, prepolymer, or oligomer, but is preferably a monomer. The molecular weight of the radical polymerizable compound is preferably 100 to 2500. The upper limit is preferably 2000 or less, more preferably 1500 or less. The lower limit is preferably 150 or more, more preferably 250 or more.

[0080] The ethylenically unsaturated bond-containing group value (hereinafter referred to as C═C value) of the radical polymerizable compound is preferably 2 to 14 mmol / g from the viewpoint of storage stability of the curable composition. The lower limit is preferably 3 mmol / g or more, more preferably 4 mmol / g or more, and even more preferably 5 mmol / g or more. The upper limit is preferably 12 mmol / g or less, more preferably 10 mmol / g or less, and even more preferably 8 mmol / g or less. The C═C value of the radical polymerizable compound is a value calculated by dividing the number of ethylenically unsaturated bond-containing groups contained in one molecule of the radical polymerizable compound by the molecular weight of the radical polymerizable compound.

[0081] The radical polymerizable compound is preferably a compound containing three or more ethylenically unsaturated bond-containing groups, more preferably a compound containing 3 to 15 ethylenically unsaturated bond-containing groups, and even more preferably a compound containing 3 to 6 ethylenically unsaturated bond-containing groups. Furthermore, the radical polymerizable compound is preferably a trifunctional to 15-functional (meth)acrylate compound, and more preferably a trifunctional to hexafunctional (meth)acrylate compound. Specific examples of the radical polymerizable compound include the compounds described in paragraphs 0075 to 0083 of WO 2022 / 065215 and the compounds described in Taiwan Patent Application Publication No. 201832008.

[0082] Preferred examples of the radically polymerizable compound include dipentaerythritol tri(meth)acrylate (commercially available product: KAYARAD D-330, manufactured by Nippon Kayaku Co., Ltd.), dipentaerythritol tetra(meth)acrylate (commercially available product: KAYARAD D-320, manufactured by Nippon Kayaku Co., Ltd.), dipentaerythritol penta(meth)acrylate (commercially available product: KAYARAD D-310, manufactured by Nippon Kayaku Co., Ltd.), dipentaerythritol hexa(meth)acrylate (commercially available products: KAYARAD DPHA, manufactured by Nippon Kayaku Co., Ltd., and NK Ester A-DPH-12E, manufactured by Shin-Nakamura Chemical Co., Ltd.), and compounds having a structure in which the (meth)acryloyl group is bonded via an ethylene glycol and / or propylene glycol residue (e.g., SR454, SR499, commercially available from Sartomer). Examples of radical polymerizable compounds include diglycerin EO (ethylene oxide) modified (meth)acrylate (commercially available product: M-460, manufactured by Toagosei Co., Ltd.), pentaerythritol tetraacrylate (NK Ester A-TMMT, manufactured by Shin-Nakamura Chemical Co., Ltd.), and 1,6-hexanediol diacrylate (KAYARAD, manufactured by Nippon Kayaku Co., Ltd.). HDDA), RP-1040 (manufactured by Nippon Kayaku Co., Ltd.), Aronix TO-2349 (manufactured by Toagosei Co., Ltd.), NK Oligo UA-7200 (manufactured by Shin-Nakamura Chemical Co., Ltd.), DPHA-40H (manufactured by Nippon Kayaku Co., Ltd.), UA-306H, UA-306T, UA-306I, AH-600, T-600, AI-600, LINC-202UA (manufactured by Kyoeisha Chemical Co., Ltd.), 8UH-1006, 8UH-1012 (all manufactured by Taisei Fine Chemical Co., Ltd.), Light Acrylate POB-A0 (manufactured by Kyoeisha Chemical Co., Ltd.), and the like can also be used.

[0083] The radical polymerizable compound may also be a radical polymerizable compound having a fluorene skeleton. The radical polymerizable compound having a fluorene skeleton is preferably a bifunctional radical polymerizable compound. Examples of the radical polymerizable compound having a fluorene skeleton include compounds having a partial structure represented by the following formula (Fr):

[0084] In the formula, * represents a bond, and Rf1 and R f2 each independently represents a substituent, and m and n each independently represent an integer of 0 to 5. When m is 2 or more, m R f1 may be the same or different, and m R f1 Two of the R f1 When n is 2 or more, n R f2 may be the same or different, and n R f2 Two of the R f2 They may be bonded to each other to form a ring. f1 and R f2 The substituent represented by is a halogen atom, a cyano group, a nitro group, an alkyl group, an aryl group, a heteroaryl group, -OR f11 , -COR f12 , -COOR f13 , -OCOR f14 , -NR f15 R f16 , -NHCOR f17 , -CONR f18 R f19 , -NHCONR f20 R f21 , -NHCOOR f22 , -SR f23 , -SO 2 R f24 , -SO 2 OR f25 , -NHSO 2 R f26 or -SO 2 NR f27 R f28 Examples include: R f11 ~R f28 each independently represents a hydrogen atom, an alkyl group, an aryl group, or a heteroaryl group.

[0085] Specific examples of radically polymerizable compounds having a fluorene skeleton include compounds having the following structure: Furthermore, commercially available products of radically polymerizable compounds having a fluorene skeleton include OGSOL EA-0200 and EA-0300 (manufactured by Osaka Gas Chemicals Co., Ltd., (meth)acrylate monomers having a fluorene skeleton).

[0086] The content of the radical polymerizable compound in the total solid content of the curable composition is preferably 1 to 30% by mass. The upper limit is preferably 20% by mass or less, more preferably 15% by mass or less, and even more preferably 10% by mass or less. The lower limit is preferably 3% by mass or more, and more preferably 5% by mass or more. The content of the radical polymerizable compound is preferably 10 to 500 parts by mass per 100 parts by mass of the total of the specific oxime ester compound (E) and the specific oxime ester compound (Z). The upper limit is preferably 400 parts by mass or less, more preferably 300 parts by mass or less, and even more preferably 200 parts by mass or less. The lower limit is preferably 20 parts by mass or more, more preferably 30 parts by mass or more, and even more preferably 50 parts by mass or more. The curable composition of the present invention may contain only one type of radical polymerizable compound, or may contain two or more types. When two or more types of radical polymerizable compounds are contained, the total amount thereof preferably falls within the above-mentioned range.

[0087] <<Resin>> The curable composition of the present invention preferably contains a resin. The resin is blended, for example, for the purpose of dispersing pigments and the like in the curable composition or for the purpose of using as a binder. Note that a resin used mainly for dispersing pigments and the like in the curable composition is also called a dispersant. However, such uses of the resin are only examples, and the resin can also be used for purposes other than these uses.

[0088] The weight average molecular weight (Mw) of the resin is preferably 3,000 to 2,000,000. The upper limit is preferably 1,000,000 or less, and more preferably 500,000 or less. The lower limit is preferably 4,000 or more, and more preferably 5,000 or more.

[0089] Examples of resins include (meth)acrylic resins, epoxy resins, (meth)acrylamide resins, ene-thiol resins, polycarbonate resins, polyether resins, polyarylate resins, polysulfone resins, polyethersulfone resins, polyphenylene resins, polyarylene ether phosphine oxide resins, polyimide resins, polyamideimide resins, polyolefin resins, cyclic olefin resins, polyester resins, styrene resins, and siloxane resins. Further, examples of the resin include the resins described in paragraphs 0091 to 0099 of WO 2022 / 065215, the blocked polyisocyanate resins described in JP 2016-222891 A, the resins described in JP 2020-122052 A, the resins described in JP 2020-111656 A, the resins described in JP 2020-139021 A, and the resins described in JP 2017-138503 A having a structural unit having a ring structure in the main chain and a biphenyl group in the side chain. Resins containing structural units, resins described in paragraphs 0199 to 0233 of JP-A-2020-186373, alkali-soluble resins described in JP-A-2020-186325, resins represented by formula 1 described in Korean Patent Publication No. 10-2020-0078339, copolymers containing epoxy groups and acid groups described in WO 2022 / 030445, resins described in JP-A-2018-135514, and copolymers described in JP-A-2020-041046 can also be used.

[0090] The resin to be used is preferably a resin having an acid group, such as a carboxy group, a phosphate group, a sulfo group, or a phenolic hydroxy group.

[0091] The acid value of the resin having acid groups is preferably 30 to 500 mgKOH / g. The lower limit is preferably 40 mgKOH / g or more, and more preferably 50 mgKOH / g or more. The upper limit is preferably 400 mgKOH / g or less, more preferably 300 mgKOH / g or less, and even more preferably 200 mgKOH / g or less. The weight average molecular weight (Mw) of the resin having acid groups is preferably 5,000 to 100,000, and more preferably 5,000 to 50,000. The number average molecular weight (Mn) of the resin having acid groups is preferably 1,000 to 20,000.

[0092] The resin having an acid group preferably contains a repeating unit having an acid group on a side chain, and more preferably contains 5 to 70 mol% of the repeating units having an acid group on a side chain based on all repeating units of the resin. The upper limit of the content of repeating units having an acid group on a side chain is preferably 50 mol% or less, more preferably 30 mol% or less. The lower limit of the content of repeating units having an acid group on a side chain is preferably 10 mol% or more, more preferably 20 mol% or more.

[0093] For resins having acid groups, please refer to the descriptions in paragraphs

[0558] to

[0571] of JP 2012-208494 A (corresponding to paragraphs

[0685] to

[0700] of U.S. Patent Application Publication No. 2012 / 0235099 A) and paragraphs

[0076] to

[0099] of JP 2012-198408 A, the contents of which are incorporated herein by reference. Alternatively, commercially available resins having acid groups can be used. There are no particular limitations on the method for introducing acid groups into the resin, and examples include the method described in Japanese Patent No. 6,349,629 A. Furthermore, examples of methods for introducing acid groups into the resin include a method in which an acid anhydride is reacted with a hydroxy group generated by a ring-opening reaction of an epoxy group to introduce the acid group.

[0094] The curable composition of the present invention also preferably contains a resin having a basic group. The resin having a basic group is preferably a resin containing a repeating unit having a basic group in a side chain, more preferably a copolymer having a repeating unit having a basic group in a side chain and a repeating unit not containing a basic group, and even more preferably a block copolymer having a repeating unit having a basic group in a side chain and a repeating unit not containing a basic group. The resin having a basic group can also be used as a dispersant. The amine value of the resin having a basic group is preferably 5 to 300 mgKOH / g. The lower limit is preferably 10 mgKOH / g or more, more preferably 20 mgKOH / g or more. The upper limit is preferably 200 mgKOH / g or less, more preferably 100 mgKOH / g or less.

[0095] Commercially available resins having basic groups include DISPERBYK-161, 162, 163, 164, 166, 167, 168, 174, 182, 183, 184, 185, 2000, 2001, 2050, 2150, 2163, 2164, and BYK-LPN6919 (all manufactured by BYK-Chemie), and Solsperse 112. 00, 13240, 13650, 13940, 24000, 26000, 28000, 32000, 32500, 32550, 32600, 33000, 34750, 35100, 35200, 37500, 38500, 39000, 53095, 56000, 7100 (all manufactured by The Lubrizol Group, Japan), Efka PX 4300, 4330, 4046, 4060, 4080 (all manufactured by BASF), and the like. In addition, the resin having a basic group may be the block copolymer (B) described in paragraphs 0063 to 0112 of JP-A-2014-219665, the block copolymer A1 described in paragraphs 0046 to 0076 of JP-A-2018-156021, or the vinyl resin having a basic group described in paragraphs 0150 to 0153 of JP-A-2019-184763, the contents of which are incorporated herein by reference.

[0096] The curable composition of the present invention also preferably contains both a resin having an acid group and a resin having a basic group. According to this embodiment, the storage stability of the curable composition can be further improved. When a resin having an acid group and a resin having a basic group are used in combination, the content of the resin having a basic group is preferably 20 to 500 parts by mass, more preferably 30 to 300 parts by mass, and even more preferably 50 to 200 parts by mass per 100 parts by mass of the resin having an acid group.

[0097] It is also preferable to use a resin having an aromatic carboxy group as the resin. In a resin having an aromatic carboxy group, the aromatic carboxy group may be contained in the main chain of the repeating unit or may be contained in a side chain of the repeating unit. It is preferable that the aromatic carboxy group is contained in the main chain of the repeating unit. In this specification, an aromatic carboxy group refers to a group having a structure in which one or more carboxy groups are bonded to an aromatic ring. In the aromatic carboxy group, the number of carboxy groups bonded to the aromatic ring is preferably 1 to 4, and more preferably 1 to 2. Examples of resins having an aromatic carboxy group include the resins described in paragraphs 0082 to 0107 of WO 2021 / 166858.

[0098] The curable composition of the present invention preferably contains a resin as a dispersant. Examples of dispersants include acidic dispersants (acidic resins) and basic dispersants (basic resins). Here, the term "acidic dispersant (acidic resin)" refers to a resin in which the amount of acid groups is greater than the amount of basic groups. As the acidic dispersant (acidic resin), a resin in which the amount of acid groups is 70 mol% or more is preferred, assuming that the total amount of acid groups and basic groups is 100 mol%. The acid group possessed by the acidic dispersant (acidic resin) is preferably a carboxy group. The acid value of the acidic dispersant (acidic resin) is preferably 10 to 105 mgKOH / g. Furthermore, the term "basic dispersant (basic resin)" refers to a resin in which the amount of basic groups is greater than the amount of acid groups. As the basic dispersant (basic resin), a resin in which the amount of basic groups is greater than 50 mol% is preferred, assuming that the total amount of acid groups and basic groups is 100 mol%. The basic group possessed by the basic dispersant is preferably an amino group.

[0099] The resin used as the dispersant is preferably a graft resin. For details of the graft resin, please refer to the description in paragraphs 0025 to 0094 of JP 2012-255128 A, the contents of which are incorporated herein by reference.

[0100] The resin used as the dispersant is preferably a resin having an aromatic carboxy group, such as those mentioned above.

[0101] The resin used as the dispersant is preferably a polyimine-based dispersant containing a nitrogen atom in at least one of the main chain and the side chain. The polyimine-based dispersant is preferably a resin having a main chain with a partial structure containing a functional group with a pKa of 14 or less and a side chain having 40 to 10,000 atoms, and having a basic nitrogen atom in at least one of the main chain and the side chain. There are no particular restrictions on the basic nitrogen atom, as long as it is a nitrogen atom that exhibits basicity. For details about polyimine-based dispersants, please refer to the description in paragraphs 0102 to 0166 of JP 2012-255128 A, the contents of which are incorporated herein by reference.

[0102] The resin used as a dispersant is preferably a resin having a structure in which multiple polymer chains are bonded to a core portion. Examples of such resins include dendrimers (including star-shaped polymers). Specific examples of dendrimers include polymer compounds C-1 to C-31 described in paragraphs 0196 to 0209 of JP-A-2013-043962.

[0103] The resin used as a dispersant is also preferably a resin containing a repeating unit having an ethylenically unsaturated bond-containing group in a side chain. The content of the repeating unit having an ethylenically unsaturated bond-containing group in a side chain is preferably 10 mol % or more, more preferably 10 to 80 mol %, and even more preferably 20 to 70 mol %, of all repeating units of the resin.

[0104] As the dispersant, the resin described in JP 2018-087939 A, the block copolymers (EB-1) to (EB-9) described in paragraphs 0219 to 0221 of Japanese Patent No. 6432077 A, polyethyleneimine having a polyester side chain described in WO 2016 / 104803, block copolymers described in WO 2019 / 125940 A, block polymers having an acrylamide structural unit described in JP 2020-066687 A, block polymers having an acrylamide structural unit described in JP 2020-066688 A, dispersants described in WO 2016 / 104803, and the like can also be used.

[0105] Dispersants are also available as commercially available products, and specific examples thereof include the DISPERBYK series manufactured by BYK Chemie, the SOLSPERSE series manufactured by Lubrizol Japan, the Efka series manufactured by BASF, and the AJISPER series manufactured by Ajinomoto Fine-Techno Co., Ltd. In addition, the products described in paragraph 0129 of JP 2012-137564 A and the products described in paragraph 0235 of JP 2017-194662 A can also be used as dispersants.

[0106] The content of the resin in the total solid content of the curable composition is preferably 1 to 60% by mass. The lower limit is preferably 5% by mass or more, more preferably 10% by mass or more, even more preferably 15% by mass or more, and particularly preferably 20% by mass or more. The upper limit is preferably 50% by mass or less, and more preferably 40% by mass or less. The content of the resin having an acid group in the total solid content of the curable composition is preferably 1 to 60% by mass. The lower limit is preferably 5% by mass or more, more preferably 10% by mass or more, even more preferably 15% by mass or more, and particularly preferably 20% by mass or more. The upper limit is preferably 50% by mass or less, and more preferably 40% by mass or less.

[0107] The content of the resin is preferably 100 to 1,000 parts by mass per 100 parts by mass of the radical polymerizable compound. The lower limit is preferably 150 parts by mass or more, and more preferably 200 parts by mass or more. The upper limit is preferably 600 parts by mass or less, and more preferably 500 parts by mass or less. The curable composition of the present invention may contain only one type of resin, or may contain two or more types. When two or more types of resins are contained, the total amount thereof is preferably within the above range.

[0108] <<Colorant>> The curable composition of the present invention preferably contains a colorant. Examples of the colorant include a white colorant, a black colorant, a chromatic colorant, and a near-infrared absorbing colorant. In the present invention, the white colorant includes not only pure white colorants but also light gray colorants close to white (for example, grayish white, light gray, etc.).

[0109] The coloring material may be a pigment or a dye. A pigment and a dye may be used in combination. The pigment may be either an inorganic pigment or an organic pigment, but is preferably an organic pigment from the viewpoints of a wide range of color variations, ease of dispersion, safety, etc. The coloring material preferably contains a pigment.

[0110] The average primary particle diameter of the pigment is preferably 1 to 200 nm. The lower limit is preferably 5 nm or more, more preferably 10 nm or more. The upper limit is preferably 180 nm or less, more preferably 150 nm or less, and even more preferably 100 nm or less. In this specification, the primary particle diameter of the pigment can be determined from a photograph obtained by observing the primary particles of the pigment with a transmission electron microscope. Specifically, the projected area of ​​the primary particles of the pigment is determined, and the corresponding circle-equivalent diameter is calculated as the primary particle diameter of the pigment.

[0111] The crystallite size of the pigment, determined from the half-width of a peak derived from any crystal plane in an X-ray diffraction spectrum obtained using CuKα radiation as an X-ray source, is preferably 0.1 to 100 nm, more preferably 0.5 to 50 nm, even more preferably 1 to 30 nm, and particularly preferably 5 to 25 nm.

[0112] The specific surface area of ​​the pigment is 1 to 300 m 2 / g. The lower limit is 10 m 2 / g or more, and 2 / g or more is more preferable. 2 / g or less, and 2 The value of the specific surface area can be determined according to the BET (Brunauer, Emmett and Teller) method in accordance with DIN 66131: Determination of the specific surface area of ​​solids by gas adsorption.

[0113] (Chromatic Colorant) Examples of chromatic colorants include colorants having a maximum absorption wavelength in the wavelength range of 400 to 700 nm, such as green colorants, red colorants, yellow colorants, purple colorants, blue colorants, and orange colorants.

[0114] Examples of the red colorant include a diketopyrrolopyrrole compound, an anthraquinone compound, an azo compound, a naphthol compound, an azomethine compound, a xanthene compound, a quinacridone compound, a perylene compound, and a thioindigo compound, and the like, preferably a diketopyrrolopyrrole compound, an anthraquinone compound, or an azo compound, and more preferably a diketopyrrolopyrrole compound. The red colorant is preferably a pigment (red pigment), and more preferably a diketopyrrolopyrrole pigment.

[0115] Specific examples of red colorants include C.I. (Color Index) Pigment Red 1, 2, 3, 4, 5, 6, 7, 9, 10, 14, 17, 22, 23, 31, 38, 41, 48:1, 48:2, 48:3, 48:4, 49, 49:1, 49:2, 52:1, 52:2, 53:1, 57:1, 60:1, 63:1, 66, 67, 81:1, 81:2, 81:3, 83, 88, 90, 105, 112, 119, 122, 123, 144, 146, 149, Examples of red pigments include 150,155,166,168,169,170,171,172,175,176,177,178,179,184,185,187,188,190,200,202,206,207,208,209,210,216,220,224,226,242,246,254,255,264,269,270,272,279,291,294,295,296,297. In addition, as a red colorant, a compound described in paragraph number 0034 of WO 2022 / 085485, or a brominated diketopyrrolopyrrole compound described in JP-A-2020-085947 can also be used.

[0116] As the red colorant, C.I. Pigment Red 122, 177, 224, 254, 255, 264, 269, 272, and 291 are preferred, C.I. Pigment Red 254, 264, and 272 are more preferred, and C.I. Pigment Red 254 and 264 are even more preferred.

[0117] Examples of the green colorant include phthalocyanine compounds and squarylium compounds, and the phthalocyanine compounds are preferred. The green colorant is preferably a pigment (green pigment), and more preferably a phthalocyanine pigment.

[0118] Specific examples of green colorants include green pigments such as C.I. Pigment Green 7, 10, 36, 37, 58, 59, 62, 63, 64, 65, and 66. Furthermore, halogenated zinc phthalocyanine pigments having an average of 10 to 14 halogen atoms, an average of 8 to 12 bromine atoms, and an average of 2 to 5 chlorine atoms per molecule can also be used as green colorants. Specific examples include the compounds described in WO 2015 / 118720. Furthermore, compounds described in paragraph 0029 of WO 2022 / 085485, aluminum phthalocyanine compounds described in JP-A 2020-070426, and diarylmethane compounds described in JP-A 2020-504758 can also be used as green colorants.

[0119] As the green colorant, C.I. Pigment Green 7, 36, 58, 62, and 63 are preferred.

[0120] Examples of orange colorants include diketopyrrolopyrrole compounds and azo compounds. The orange colorant is preferably a pigment (orange pigment). Specific examples of orange colorants include orange pigments such as C.I. Pigment Orange 2, 5, 13, 16, 17:1, 31, 34, 36, 38, 43, 46, 48, 49, 51, 52, 55, 59, 60, 61, 62, 64, 71, and 73.

[0121] Examples of the yellow colorant include an azo compound, an azomethine compound, an isoindoline compound, a pteridine compound, a quinophthalone compound, and a perylene compound. The yellow colorant is preferably a pigment (yellow pigment). Specific examples of the yellow colorant include C.I. Pigment Yellow 1, 2, 3, 4, 5, 6, 10, 11, 12, 13, 14, 15, 16, 17, 18, 20, 24, 31, 32, 34, 35, 35:1, 36, 36:1, 37, 37:1, 40, 42, 43, 53, 55, 60, 61, 62, 63, 65, 73, 74, 77, 81, 83, 86, 93, 94, 95, 97, 98, 100, 101, 104, 106, 108, 109, 110, 113, 114, 115, 116, 117, 118, 119, 120, 123, 125 , 126, 127, 128, 129, 137, 138, 139, 147, 148, 150, 151, 152, 153, 154, 155, 156, 161, 162, 164, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 179, 180, 181, 182, 185, 187, 188, 193, 194, 199, 213, 214, 215, 228, 231, 232, 233, 234, 235, 236 and the like.

[0122] As the yellow coloring material, an azobarbituric acid nickel complex having the following structure can also be used.

[0123] As the yellow colorant, the compounds described in paragraphs 0031 to 0033 of WO 2022 / 085485, the methine dyes described in JP-A 2019-073695, and the methine dyes described in JP-A 2019-073696 can be used.

[0124] Examples of the purple colorant include an oxazine compound, a quinacridone compound, a perylene compound, and an indigo compound, and the oxazine compound is preferred. The purple colorant is preferably a pigment (purple pigment). Specific examples of the purple colorant include purple pigments such as C.I. Pigment Violet 1, 19, 23, 27, 32, 37, 42, 60, and 61.

[0125] Examples of blue colorants include phthalocyanine compounds and squarylium compounds, with phthalocyanine compounds being preferred. The blue colorant is preferably a pigment (blue pigment). Specific examples of blue colorants include blue pigments such as C.I. Pigment Blue 1, 2, 15, 15:1, 15:2, 15:3, 15:4, 15:6, 16, 22, 29, 60, 64, 66, 79, 80, 87, and 88. Furthermore, aluminum phthalocyanine compounds having phosphorus atoms can also be used as blue colorants. Specific examples include the compounds described in paragraphs 0022 to 0030 of JP-A No. 2012-247591 and paragraph 0047 of JP-A No. 2011-157478.

[0126] Dyes can also be used as chromatic colorants. There are no particular limitations on the dyes, and known dyes can be used. Examples include pyrazole azo dyes, anilino azo dyes, triarylmethane dyes, anthraquinone dyes, anthrapyridone dyes, benzylidene dyes, oxonol dyes, pyrazolotriazole azo dyes, pyridone azo dyes, cyanine dyes, phenothiazine dyes, pyrrolopyrazole azomethine dyes, xanthene dyes, phthalocyanine dyes, benzopyran dyes, indigo dyes, and pyrromethene dyes.

[0127] A dye polymer can also be used as a chromatic colorant. The dye polymer is preferably a dye dissolved in a solvent when used. The dye polymer may also form particles. When the dye polymer is particulate, it is typically used in a dispersed state in a solvent. A particulate dye polymer can be obtained, for example, by emulsion polymerization, and specific examples of the compounds and production methods described in JP-A 2015-214682 include those described in JP-A 2015-214682. The dye polymer has two or more dye structures in one molecule, preferably three or more dye structures. The upper limit is not particularly limited, but can be 100 or less. The multiple dye structures in one molecule may be the same dye structure or different dye structures. The weight-average molecular weight (Mw) of the dye polymer is preferably 2,000 to 50,000. The lower limit is more preferably 3,000 or more, and even more preferably 6,000 or more. The upper limit is more preferably 30,000 or less, and even more preferably 20,000 or less. As the dye multimer, compounds described in JP-A-2011-213925, JP-A-2013-041097, JP-A-2015-028144, JP-A-2015-030742, WO 2016 / 031442, etc. can also be used.

[0128] As chromatic colorants, triarylmethane dye polymers described in Korean Patent Publication No. 10-2020-0028160, xanthene compounds described in JP 2020-117638 A, phthalocyanine compounds described in WO 2020 / 174991 A, isoindoline compounds described in JP 2020-160279 A or salts thereof, compounds represented by formula 1 described in Korean Patent Publication No. 10-2020-0069442 A, compounds represented by formula 1 described in Korean Patent Publication No. 10-2020-0069730 A, compounds represented by formula 1 described in Korean Patent Publication No. 10-2020-0069070 A Compounds represented by the formula 1 described in Korean Patent Publication No. 10-2020-0069067, compounds represented by the formula 1 described in Korean Patent Publication No. 10-2020-0069062, halogenated zinc phthalocyanine pigments described in Japanese Patent No. 6809649, isoindoline compounds described in JP-A-2020-180176, phenothiazine compounds described in JP-A-2021-187913, halogenated zinc phthalocyanines described in WO 2022 / 004261, and halogenated zinc phthalocyanines described in WO 2021 / 250883 can be used. The chromatic colorant may be a rotaxane, and the dye skeleton may be used in the cyclic structure of the rotaxane, in the rod-shaped structure, or in both structures.As chromatic colorants, quinophthalone compounds represented by formula 1 in Korean Patent Publication No. 10-2020-0030759, polymer dyes described in Korean Patent Publication No. 10-2020-0061793, chromatic colorants described in JP-A-2022-029701, isoindoline compounds described in WO 2022 / 014635, aluminum phthalocyanine compounds described in WO 2022 / 024926, compounds described in JP-A-2022-045895, and compounds described in WO 2022 / 050051. compounds described in JP 2020-090676 A, compounds described in JP 2020-055956 A, compounds described in JP 2021-031681 A, compounds described in JP 2022-056354 A, compounds described in US Patent Application Publication No. 2021 / 0355327, compounds described in WO 2022 / 065357, compounds described in JP 2020-045436 A, compounds described in Korean Patent Publication No. 10-2021-0146726, compounds described in JP 2018-178039 A compounds described in Chinese Patent Application Publication No. 113881244, compounds described in Chinese Patent Application Publication No. 113881245, compounds described in Chinese Patent Application Publication No. 113881246, compounds described in JP 2022-104822 A, compounds described in JP 2022-096701 A, compounds described in JP 2020-023652 A, green pigments described on pages 80 to 84 of the Journal of the Japan Color Materials Association (published in 2022), compounds described in JP 2022-143135 A, compounds described in JP 2022- Compounds described in JP-A-140287, compounds described in WO 2022 / 136308, perylene compounds described in Chinese Patent Application Publication No. 113061349, cyan pigments described in Korean Patent Publication No. 10-2017-0018993, isoindoline compounds described in JP-A-2020-180176, compounds described in JP-A-2023-013209, compounds described in JP-A-2023-013166, xanthene compounds described in WO 2023 / 286526, and the like can also be used.

[0129] Two or more chromatic colorants may be used in combination. When two or more chromatic colorants are used in combination, the combination of the two or more chromatic colorants may form a black color. Examples of such combinations include the following embodiments (1) to (7). When the curable composition contains two or more chromatic colorants and exhibits a black color through the combination of the two or more chromatic colorants, the curable composition of the present invention can be preferably used as a curable composition for forming a near-infrared transmission filter. (1) An embodiment containing a red colorant and a blue colorant. (2) An embodiment containing a red colorant, a blue colorant, and a yellow colorant. (3) An embodiment containing a red colorant, a blue colorant, a yellow colorant, and a purple colorant. (4) An embodiment containing a red colorant, a blue colorant, a yellow colorant, a purple colorant, and a green colorant. (5) An embodiment containing a red colorant, a blue colorant, a yellow colorant, and a green colorant. (6) An embodiment containing a red colorant, a blue colorant, and a green colorant. (7) An embodiment containing a yellow coloring material and a purple coloring material.

[0130] (White coloring material) Examples of the white coloring material include inorganic pigments such as titanium oxide, strontium titanate, barium titanate, zinc oxide, magnesium oxide, zirconium oxide, aluminum oxide, barium sulfate, silica, talc, mica, aluminum hydroxide, calcium silicate, aluminum silicate, and zinc sulfide. As the white coloring material, the white pigments described in paragraphs 0040 to 0043 of WO 2022 / 085485 can be used.

[0131] (Black Colorant) The black colorant is not particularly limited, and known materials can be used. The black colorant may be an inorganic black colorant or an organic black colorant. The black colorant is preferably a pigment. In this specification, the black colorant refers to a colorant that exhibits absorption over the entire wavelength range of 400 to 700 nm.

[0132] Examples of inorganic black colorants include carbon black, titanium black, graphite, etc., with carbon black and titanium black being preferred, and titanium black being more preferred. Titanium black is a black particle containing titanium atoms, and low-order titanium oxide or titanium oxynitride is preferred. Titanium black can be used as described in paragraph 0044 of WO 2022 / 085485.

[0133] Examples of organic black colorants include bisbenzofuranone compounds, azomethine compounds, perylene compounds, and azo compounds, with bisbenzofuranone compounds and perylene compounds being preferred. The organic black colorant may be a compound described in paragraph 0166 of International Publication No. 2022 / 065215. Furthermore, examples of organic black colorants include perylene black (such as Lumogen Black FK4280) described in paragraphs 0016 to 0020 of JP-A-2017-226821 and black azo pigments described in JP-A-2022-121935.

[0134] (Near-infrared absorbing colorant) The near-infrared absorbing colorant is preferably a compound having a maximum absorption wavelength longer than 700 nm. The near-infrared absorbing colorant is preferably a compound having a maximum absorption wavelength in the wavelength range of more than 700 nm to 1800 nm, more preferably a compound having a maximum absorption wavelength in the wavelength range of more than 700 nm to 1400 nm, even more preferably a compound having a maximum absorption wavelength in the wavelength range of more than 700 nm to 1200 nm, and particularly preferably a compound having a maximum absorption wavelength in the wavelength range of more than 700 nm to 1000 nm. In addition, the absorbance A of the near-infrared absorbing colorant at a wavelength of 500 nm is 1 and absorbance A at the maximum absorption wavelength 2 Ratio A 1 / A 2 is preferably 0.08 or less, more preferably 0.04 or less. The near-infrared absorbing colorant is preferably a pigment, more preferably an organic pigment.

[0135] Examples of near-infrared absorbing colorants include pyrrolopyrrole compounds, cyanine compounds, squarylium compounds, phthalocyanine compounds, naphthalocyanine compounds, quaterrylene compounds, merocyanine compounds, croconium compounds, oxonol compounds, iminium compounds, dithiol compounds, triarylmethane compounds, pyrromethene compounds, azomethine compounds, anthraquinone compounds, dibenzofuranone compounds, dithiolene metal complexes, metal oxides, and metal borides. Specific examples of these include the compounds described in paragraph 0114 of WO 2022 / 065215. Examples of infrared absorbing colorants include the compounds described in paragraph 0121 of WO 2022 / 065215, squarylium compounds described in JP 2020-075959 A, Copper complexes described in Korean Patent Publication No. 10-2019-0135217, JP 2021-195515 croconic acid compounds described in JP 2022-022070 near-infrared absorbing dyes described in WO 2019 / 021767, croconium compounds described in JP 2019-127549, compounds described in WO 2022 / 059619, compounds described in JP 2022-151682, squarylium compounds described in JP 2022-188858, compounds described in JP 2022-184710, compounds described in JP 2022-189736 can also be used.

[0136] The content of the colorant in the total solid content of the curable composition is preferably 30 to 80% by mass, with the upper limit being preferably 70% by mass or less, and more preferably 65% ​​by mass or less, and the lower limit being preferably 35% by mass or more, and more preferably 40% by mass or more.

[0137] The content of the pigment in the total solid content of the curable composition is preferably 20 to 80% by mass. The upper limit is preferably 75% by mass or less, more preferably 65% ​​by mass or less, and even more preferably 63% by mass or less. The lower limit is preferably 25% by mass or more, more preferably 30% by mass or more, and even more preferably 35% by mass or more. According to the curable composition of the present invention, even when the pigment content is high, it is possible to form a film in which foreign matter defects are suppressed, and therefore, when the pigment content is high, the effects of the present invention are more pronounced.

[0138] The content of the pigment in the coloring material is preferably 20 to 100% by mass, more preferably 50 to 100% by mass, and even more preferably 70 to 100% by mass.

[0139] <<Chain Transfer Agent>> The curable composition of the present invention preferably contains a chain transfer agent. According to this embodiment, it is possible to further increase the sensitivity when exposed to light having a wavelength of 150 nm to 300 nm, such as KrF radiation. Examples of the chain transfer agent include a thiol compound, a thiocarbonylthio compound, and an aromatic α-methylalkenyl dimer, and a thiol compound is preferred. Examples of the chain transfer agent include the compounds described in paragraphs 0093 to 0113 of WO 2019 / 188652.

[0140] The thiol compound used as a chain transfer agent is a compound having one or more thiol groups, preferably a compound having two or more thiol groups. The upper limit of the number of thiol groups contained in the thiol compound is preferably 10 or less, more preferably 6 or less, and even more preferably 4 or less. The thiol compound is particularly preferably a compound having two thiol groups.

[0141] The thiol compound is preferably a compound represented by the following formula (SH-1): S1 - (SH) n Formula (SH-1) (wherein SH represents a thiol group, L 1 represents an n-valent group, where n is an integer of 1 or more.

[0142] L in formula (SH-1) S1 The n-valent group represented by is a hydrocarbon group, a heterocyclic group, —O—, —S—, —NR S1 -, -CO-, -COO-, -OCO-, -SO 2 - or a group consisting of a combination thereof. S1 represents a hydrogen atom, an alkyl group, or an aryl group, with a hydrogen atom being preferred. The hydrocarbon group may be an aliphatic hydrocarbon group or an aromatic hydrocarbon group. The aliphatic hydrocarbon group may be cyclic or acyclic. The aliphatic hydrocarbon group may be a saturated aliphatic hydrocarbon group or an unsaturated aliphatic hydrocarbon group. The hydrocarbon group may have a substituent or may not have a substituent. The cyclic aliphatic hydrocarbon group and the aromatic hydrocarbon group may be a monocyclic or fused ring. The heterocyclic group may be a monocyclic or fused ring. The heterocyclic group is preferably a 5- or 6-membered ring. The heterocyclic group may be an aliphatic heterocyclic group or an aromatic heterocyclic group. Examples of heteroatoms constituting the heterocyclic group include a nitrogen atom, an oxygen atom, and a sulfur atom. L 1 The number of carbon atoms constituting the group is preferably 3 to 100, and more preferably 6 to 50.

[0143] In formula (SH-1), n ​​represents an integer of 1 or more. The upper limit of n is preferably 10 or less, more preferably 6 or less, and even more preferably 4 or less. The lower limit of n is preferably 2 or more.

[0144] Specific examples of the thiol compound include the compounds described in the Examples below and the compounds described in paragraphs 0100 to 0103 of WO 2019 / 188652. Commercially available thiol compounds include PEMP (manufactured by SC Organic Chemical Co., Ltd.), Suncera M (manufactured by Sanshin Chemical Industry Co., Ltd.), Karenz MTBD1, Karenz MTPE1, Karenz MTNR1, and Karenz MTTPMB (all manufactured by Resonac Corporation).

[0145] The molecular weight of the chain transfer agent is preferably 200 or more. The upper limit is preferably 1000 or less, more preferably 800 or less, and even more preferably 600 or less, because the SH valence per weight can be increased.

[0146] The content of the chain transfer agent in the total solid content of the curable composition is preferably 0.001 to 5% by mass. The upper limit is preferably 3% by mass or less, more preferably 1% by mass or less. The lower limit is preferably 0.05% by mass or more, more preferably 0.01% by mass or more. The content of the chain transfer agent is preferably 0.1 to 200 parts by mass per 100 parts by mass of the total of the specific oxime ester compound (E) and the specific oxime ester compound (Z). The upper limit is preferably 100 parts by mass or less, more preferably 50 parts by mass or less. The lower limit is preferably 0.5 parts by mass or more, more preferably 1 part by mass or more. Only one type of chain transfer agent may be used, or two or more types may be used. When two or more types are used, it is preferable that the total amount thereof is within the above range.

[0147] <<Pigment Derivative>> The curable composition of the present invention may contain a pigment derivative. The pigment derivative is used, for example, as a dispersing aid. A dispersing aid is a material that enhances the dispersibility of a colorant such as a pigment in the curable composition.

[0148] Examples of the pigment derivative include a compound having at least one structure selected from the group consisting of a dye structure and a triazine structure, and an acid group or a basic group.

[0149] Examples of the dye structure include a quinoline dye structure, a benzimidazolone dye structure, a benzisoindole dye structure, a benzothiazole dye structure, an iminium dye structure, a squarylium dye structure, a croconium dye structure, an oxonol dye structure, a pyrrolopyrrole dye structure, a diketopyrrolopyrrole dye structure, an azo dye structure, an azomethine dye structure, a phthalocyanine dye structure, a naphthalocyanine dye structure, an anthraquinone dye structure, a quinacridone dye structure, a dioxazine dye structure, a perinone dye structure, a perylene dye structure, a thiazineindigo dye structure, a thioindigo dye structure, an isoindoline dye structure, an isoindolinone dye structure, a quinophthalone dye structure, a dithiol dye structure, a triarylmethane dye structure, and a pyrromethene dye structure.

[0150] Examples of the acid group possessed by the pigment derivative include a carboxy group, a sulfo group, a phosphate group, a boronic acid group, an imidic acid group, and salts thereof. Examples of the atom or atomic group constituting the salt include an alkali metal ion (Li + , Na + , K. + etc.), alkaline earth metal ions (Ca 2+ , Mg 2+ Examples of the imide acid group include an ammonium ion, an imidazolium ion, a pyridinium ion, and a phosphonium ion. 2 NHSO 2 R X1 , -CONHSO 2 R X2 , -CONHCOR X3 or -SO 2 NHCOR X4 A group represented by the formula: 2 NHSO 2 R X1 , -CONHSO 2 R X2 , or -SO 2 NHCOR X4 A group represented by the formula: 2 NHSO 2 R X1 or -CONHSO 2 R X2 is more preferred. X1 ~RX4 R each independently represents an alkyl group or an aryl group. X1 ~R X4 The alkyl group and aryl group represented by R may have a substituent. The substituent is preferably a halogen atom, more preferably a fluorine atom. X1 ~R X4 are each independently preferably an alkyl group containing a fluorine atom or an aryl group containing a fluorine atom, and more preferably an alkyl group containing a fluorine atom. The number of carbon atoms in the alkyl group containing a fluorine atom is preferably 1 to 10, more preferably 1 to 5, and even more preferably 1 to 3. The number of carbon atoms in the aryl group containing a fluorine atom is preferably 6 to 20, more preferably 6 to 12, and even more preferably 6.

[0151] Examples of basic groups possessed by the pigment derivative include amino groups, pyridinyl groups and their salts, ammonium salts, and phthalimidomethyl groups. Examples of atoms or atomic groups that constitute the salts include hydroxide ions, halogen ions, carboxylate ions, sulfonate ions, and phenoxide ions.

[0152] The amino group is —NR x11 R x12 and a cyclic amino group.

[0153] -NR x11 R x12 In the group represented by x11 and R x12 are each independently a hydrogen atom, an alkyl group, or an aryl group, and are preferably an alkyl group. That is, the amino group is preferably a dialkylamino group. The alkyl group preferably has 1 to 10 carbon atoms, more preferably 1 to 5, and even more preferably 1 to 3. The alkyl group may be linear, branched, or cyclic, but is preferably linear or branched, and more preferably linear. The alkyl group may have a substituent. The aryl group preferably has 6 to 30 carbon atoms, more preferably 6 to 20, and even more preferably 6 to 12. The aryl group may have a substituent.

[0154] Examples of the cyclic amino group include a pyrrolidine group, a piperidine group, a piperazine group, a morpholine group, etc. These groups may further have a substituent.

[0155] The pigment derivative may be a pigment derivative having excellent visible transparency (hereinafter also referred to as a transparent pigment derivative). The maximum molar absorption coefficient (εmax) of the transparent pigment derivative in the wavelength range of 400 to 700 nm is 3000 L mol -1 ・cm -1 It is preferable that the concentration is 1000 L mol or less. -1 ・cm -1 More preferably, it is 100 L mol or less. -1 ・cm -1 The lower limit of εmax is, for example, 1 L mol -1 ・cm -1 or more, and 10 L mol -1 ・cm -1 More than that is fine.

[0156] Specific examples of pigment derivatives include the compounds described in the Examples below, the compounds described in paragraph 0124 of WO 2022 / 085485, the benzimidazolone compounds or salts thereof described in JP 2018-168244 A, and compounds having an isoindoline skeleton described in general formula (1) of Japanese Patent No. 6,996,282.

[0157] The content of the pigment derivative is preferably 1 to 30 parts by mass, and more preferably 3 to 20 parts by mass, relative to 100 parts by mass of the pigment. The total content of the pigment derivative and colorant is preferably 40% by mass or more, more preferably 50% by mass or more, and even more preferably 60% by mass or more, based on the total solid content of the curable composition. The upper limit is preferably 80% by mass or less, and more preferably 70% by mass or less. Only one type of pigment derivative may be used, or two or more types may be used in combination.

[0158] <<Polyalkyleneimine>> The curable composition of the present invention can also contain a polyalkyleneimine. The polyalkyleneimine is used, for example, as a dispersing aid for pigments. A dispersing aid is a material for improving the dispersibility of coloring materials such as pigments in a curable composition. The polyalkyleneimine is a polymer obtained by ring-opening polymerization of an alkyleneimine. The polyalkyleneimine is preferably a polymer having a branched structure containing a primary amino group, a secondary amino group, and a tertiary amino group. The alkyleneimine preferably has 2 to 6 carbon atoms, more preferably 2 to 4 carbon atoms, even more preferably 2 or 3 carbon atoms, and particularly preferably 2 carbon atoms.

[0159] The molecular weight of the polyalkyleneimine is preferably 200 or more, more preferably 250 or more. The upper limit is preferably 100,000 or less, more preferably 50,000 or less, even more preferably 10,000 or less, and particularly preferably 2,000 or less. Regarding the molecular weight value of the polyalkyleneimine, if the molecular weight can be calculated from the structural formula, the molecular weight of the polyalkyleneimine is the value calculated from the structural formula. On the other hand, if the molecular weight of the specific amine compound cannot be calculated from the structural formula or calculation is difficult, the number average molecular weight value measured by the boiling point elevation method is used. If the number average molecular weight cannot be measured by the boiling point elevation method or is difficult to measure, the number average molecular weight value measured by the viscosity method is used. If the number average molecular weight cannot be measured by the viscosity method or is difficult to measure, the number average molecular weight value measured in terms of polystyrene by GPC (gel permeation chromatography) is used.

[0160] The amine value of the polyalkyleneimine is preferably 5 mmol / g or more, more preferably 10 mmol / g or more, and even more preferably 15 mmol / g or more.

[0161] Specific examples of alkyleneimines include ethyleneimine, propyleneimine, 1,2-butyleneimine, and 2,3-butyleneimine, with ethyleneimine or propyleneimine being preferred, and ethyleneimine being more preferred. It is particularly preferred that the polyalkyleneimine be polyethyleneimine. Furthermore, the polyethyleneimine preferably contains primary amino groups in an amount of 10 mol% or more, more preferably 20 mol% or more, and even more preferably 30 mol% or more, based on the total of primary amino groups, secondary amino groups, and tertiary amino groups. Commercially available polyethyleneimines include Epomin SP-003, SP-006, SP-012, SP-018, SP-200, and P-1000 (all manufactured by Nippon Shokubai Co., Ltd.).

[0162] The content of the polyalkyleneimine in the total solid content of the curable composition is preferably 0.1 to 5% by mass. The lower limit is preferably 0.2% by mass or more, more preferably 0.5% by mass or more, and even more preferably 1% by mass or more. The upper limit is preferably 4.5% by mass or less, more preferably 4% by mass or less, and even more preferably 3% by mass or less. The content of the polyalkyleneimine is preferably 0.5 to 20 parts by mass per 100 parts by mass of the pigment. The lower limit is preferably 0.6 parts by mass or more, more preferably 1 part by mass or more, and even more preferably 2 parts by mass or more. The upper limit is preferably 10 parts by mass or less, and even more preferably 8 parts by mass or less. Only one type of polyalkyleneimine may be used, or two or more types may be used. When two or more types are used, it is preferable that the total amount thereof is within the above range.

[0163] <<Solvent>> The curable composition of the present invention preferably contains a solvent. Examples of the solvent include organic solvents. The type of solvent is basically not particularly limited as long as the solubility of each component and the coatability of the composition are satisfied. Examples of organic solvents include ester-based solvents, ketone-based solvents, alcohol-based solvents, amide-based solvents, ether-based solvents, and hydrocarbon-based solvents. For details of these, please refer to paragraph 0223 of WO 2015 / 166779, the contents of which are incorporated herein by reference. Furthermore, ester-based solvents substituted with a cyclic alkyl group and ketone-based solvents substituted with a cyclic alkyl group can also be preferably used. Specific examples of organic solvents include polyethylene glycol monomethyl ether, dichloromethane, methyl 3-ethoxypropionate, ethyl 3-ethoxypropionate, ethyl cellosolve acetate, ethyl lactate, diethylene glycol dimethyl ether, butyl acetate, methyl 3-methoxypropionate, 2-heptanone, 2-pentanone, 3-pentanone, 4-heptanone, cyclohexanone, 2-methylcyclohexanone, 3-methylcyclohexanone, 4-methylcyclohexanone, cycloheptanone, cyclooctanone, cyclohexyl acetate, cyclopentanone, ethyl carbitol acetate, butyl carbitol acetate, propylene glycol monomethyl ether ... Examples of suitable ethylene glycol monomethyl ether acetate include 3-methoxy-N,N-dimethylpropanamide, 3-butoxy-N,N-dimethylpropanamide, propylene glycol diacetate, 3-methoxybutanol, methyl ethyl ketone, gamma butyrolactone, sulfolane, anisole, 1,4-diacetoxybutane, diethylene glycol monoethyl ether acetate, butane-1,3-diyl diacetate, dipropylene glycol methyl ether acetate, diacetone alcohol (also known as diacetone alcohol, 4-hydroxy-4-methyl-2-pentanone), 2-methoxypropyl acetate, 2-methoxy-1-propanol, and isopropyl alcohol.However, it may be preferable to reduce the amount of aromatic hydrocarbons (benzene, toluene, xylene, ethylbenzene, etc.) used as organic solvents for environmental reasons (for example, the amount may be 50 ppm by mass (parts per million) or less, 10 ppm by mass or less, or 1 ppm by mass or less, relative to the total amount of organic solvents).

[0164] The metal content of the organic solvent is preferably low. The metal content of the organic solvent is preferably, for example, 10 parts per billion (ppb) by mass or less. If necessary, an organic solvent having a metal content of ppt (parts per trillion) by mass may be used, and such an organic solvent is provided, for example, by Toyo Gosei Co., Ltd. (The Chemical Daily, November 13, 2015).

[0165] Methods for removing impurities such as metals from organic solvents include, for example, distillation (molecular distillation, thin-film distillation, etc.) and filtration using a filter. The pore size of the filter used for filtration is preferably 10 μm or less, more preferably 5 μm or less, and even more preferably 3 μm or less. The filter material is preferably polytetrafluoroethylene, polyethylene, or nylon.

[0166] The organic solvent may contain isomers (compounds having the same number of atoms but different structures). The organic solvent may contain only one type of isomer or multiple types of isomers.

[0167] The organic solvent preferably has a peroxide content of 0.8 mmol / L or less, and more preferably contains substantially no peroxide.

[0168] The content of the solvent in the curable composition is preferably from 10 to 95% by mass, more preferably from 20 to 90% by mass, and even more preferably from 30 to 90% by mass.

[0169] From the viewpoint of environmental regulations, it is preferable that the curable composition of the present invention is substantially free of environmentally restricted substances. In the present invention, "substantially free of environmentally restricted substances" means that the content of environmentally restricted substances in the curable composition is 50 ppm by mass or less, preferably 30 ppm by mass or less, more preferably 10 ppm by mass or less, and particularly preferably 1 ppm by mass or less. Examples of environmentally restricted substances include benzene; alkylbenzenes such as toluene and xylene; and halogenated benzenes such as chlorobenzene. These substances are registered as environmentally restricted substances under the REACH (Registration Evaluation Authorization and Restriction of Chemicals) regulations, the PRTR (Pollutant Release and Transfer Register) Act, the VOC (Volatile Organic Compounds) regulations, etc., and their usage amounts and handling methods are strictly regulated. These compounds may be used as solvents when producing the components used in the curable composition, and may be mixed into the curable composition as residual solvents. From the viewpoints of human safety and environmental considerations, it is preferable to reduce these substances as much as possible. Examples of methods for reducing environmentally restricted substances include a method in which the system is heated or depressurized to a temperature above the boiling point of the environmentally restricted substance, thereby distilling off the environmentally restricted substance from the system. Furthermore, when distilling off a small amount of environmentally regulated substances, it is useful to perform azeotropy with a solvent having a boiling point equivalent to that of the solvent in question in order to increase efficiency. Furthermore, when a radically polymerizable compound is contained, a polymerization inhibitor or the like may be added prior to distillation under reduced pressure to prevent intermolecular crosslinking due to the progress of a radical polymerization reaction during distillation under reduced pressure. These distillation methods can be used at any stage, such as the stage of raw materials, the stage of a product obtained by reacting the raw materials (e.g., a resin solution or a polyfunctional monomer solution after polymerization), or the stage of a curable composition prepared by mixing these compounds.

[0170] <<Compound Having a Cyclic Ether Group>> The curable composition of the present invention can contain a compound having a cyclic ether group. Examples of the cyclic ether group include an epoxy group and an oxetanyl group. The epoxy group may be an alicyclic epoxy group. The alicyclic epoxy group refers to a monovalent functional group having a cyclic structure in which an epoxy ring and a saturated hydrocarbon ring are condensed. The compound having a cyclic ether group is preferably a compound having an epoxy group (hereinafter also referred to as an epoxy compound). Examples of epoxy compounds include compounds having one or more epoxy groups per molecule, and compounds having two or more epoxy groups are preferred. The epoxy compound is preferably a compound having 1 to 100 epoxy groups per molecule. The upper limit of the number of epoxy groups contained in the epoxy compound can be, for example, 10 or less, or 5 or less. The lower limit of the number of epoxy groups contained in the epoxy compound is preferably 2 or more.

[0171] Examples of compounds having a cyclic ether group include the compounds described in paragraphs 0034 to 0036 of JP-A-2013-011869, 0147 to 0156 of JP-A-2014-043556, and 0085 to 0092 of JP-A-2014-089408, and the compounds described in JP-A-2017-179172, the xanthene epoxy resins described in JP-A-2021-195421, and the xanthene epoxy resins described in JP-A-2021-195422 can be used.

[0172] The compound having a cyclic ether group may be a low molecular weight compound (for example, a molecular weight of less than 2000, or even less than 1000) or a high molecular weight compound (macromolecule) (for example, a molecular weight of 1000 or more, and in the case of a polymer, a weight average molecular weight of 1000 or more). The weight average molecular weight of the compound having a cyclic ether group is preferably 200 to 100,000, and more preferably 500 to 50,000. The upper limit of the weight average molecular weight is preferably 10,000 or less, more preferably 5,000 or less, and even more preferably 3,000 or less.

[0173] Commercially available examples of compounds having a cyclic ether group include EHPE3150 (manufactured by Daicel Corporation), EPICLON N-695 (manufactured by DIC Corporation), Marproof G-0150M, G-0105SA, G-0130SP, G-0250SP, G-1005S, G-1005SA, G-1010S, G-2050M, G-01100, and G-01758 (all manufactured by NOF Corporation, epoxy group-containing polymers).

[0174] The content of the compound having a cyclic ether group in the total solid content of the curable composition is preferably 0.1 to 20% by mass. The lower limit is preferably 0.5% by mass or more, and more preferably 1% by mass or more. The upper limit is preferably 15% by mass or less, and more preferably 10% by mass or less. Only one type of compound having a cyclic ether group may be used, or two or more types may be used. When two or more types are used, it is preferable that the total amount thereof be in the above range.

[0175] <<UV Absorber>> The curable composition of the present invention may contain an UV absorber. Examples of UV absorbers include conjugated diene compounds, aminodiene compounds, salicylate compounds, benzophenone compounds, benzotriazole compounds, acrylonitrile compounds, hydroxyphenyltriazine compounds, indole compounds, triazine compounds, and dibenzoyl compounds. Specific examples of such compounds include the compound described in paragraph 0179 of WO 2022 / 085485, the reactive triazine UV absorber described in JP 2021-178918 A, the UV absorber described in JP 2022-007884 A, and the compound described in Korean Patent Publication No. 10-2022-0014454. The content of the UV absorber in the total solids content of the curable composition is preferably 0.01 to 10% by mass, more preferably 0.01 to 5% by mass. Only one UV absorber may be used, or two or more UV absorbers may be used. When two or more types are used, the total amount thereof is preferably within the above range.

[0176] <<Polymerization Inhibitor>> The curable composition of the present invention may contain a polymerization inhibitor. Examples of polymerization inhibitors include hydroquinone, p-methoxyphenol, di-tert-butyl-p-cresol, pyrogallol, tert-butylcatechol, benzoquinone, 4,4'-thiobis(3-methyl-6-tert-butylphenol), 2,2'-methylenebis(4-methyl-6-t-butylphenol), and N-nitrosophenylhydroxyamine salts (ammonium salts, cerous salts, etc.). Of these, p-methoxyphenol is preferred. The content of the polymerization inhibitor in the total solid content of the curable composition is preferably 0.0001 to 5 mass%. One type of polymerization inhibitor may be used alone, or two or more types may be used. When two or more types are used, the total amount is preferably within the above range.

[0177] <<Silane Coupling Agent>> The curable composition of the present invention may contain a silane coupling agent. Examples of the silane coupling agent include silane compounds having a hydrolyzable group, and preferably silane compounds having a hydrolyzable group and other functional groups. The hydrolyzable group refers to a substituent directly bonded to a silicon atom that can form a siloxane bond by at least one of a hydrolysis reaction and a condensation reaction. Examples of the hydrolyzable group include a halogen atom, an alkoxy group, and an acyloxy group, with an alkoxy group being preferred. That is, the silane coupling agent is preferably a compound having an alkoxysilyl group. Examples of functional groups other than the hydrolyzable group include a vinyl group, a (meth)allyl group, a (meth)acryloyl group, a mercapto group, an epoxy group, an oxetanyl group, an amino group, a ureido group, a sulfide group, an isocyanate group, and a phenyl group, with an amino group, a (meth)acryloyl group, and an epoxy group being preferred. Specific examples of the silane coupling agent include the compound described in paragraph 0177 of WO 2022 / 085485 and the compound described in JP 2019-183020 A. The content of the silane coupling agent in the total solid content of the curable composition is preferably 0.1 to 15% by mass. The upper limit is preferably 10% by mass or less, more preferably 5% by mass or less. The lower limit is preferably 0.5% by mass or more, more preferably 1% by mass or more. Only one type of silane coupling agent may be used, or two or more types may be used. When two or more types are used, it is preferable that the total amount is within the above range.

[0178] <<Surfactant>> The curable composition of the present invention may contain a surfactant. As the surfactant, various surfactants such as a fluorine-based surfactant, a nonionic surfactant, a cationic surfactant, an anionic surfactant, and a silicone-based surfactant may be used. The surfactant is preferably a silicone-based surfactant or a fluorine-based surfactant, and more preferably a silicone-based surfactant. For details of the surfactant, reference may be made to the surfactants described in paragraphs 0238 to 0245 of WO 2015 / 166779, the contents of which are incorporated herein by reference.

[0179] As the fluorine-based surfactant, compounds described in paragraphs 0167 to 0173 of WO 2022 / 085485 can be used.

[0180] Examples of nonionic surfactants include the compounds described in paragraph 0174 of WO 2022 / 085485.

[0181] Silicone surfactants include DOWSIL SH8400, SH8400 FLUID, FZ-2122, 67 Additive, 74 Additive, M Additive, and SF 8419. OIL (all manufactured by Dow Toray Industries, Inc.), TSF-4300, TSF-4445, TSF-4460, TSF-4452 (all manufactured by Momentive Performance Materials), KP-341, KF-6000, KF-6001, KF-6002, KF-6003 (all manufactured by Shin-Etsu Chemical Co., Ltd.), BYK-307, BYK-322, BYK-323, BYK-330, BYK-333, BYK-3760, BYK-UV3510 (all manufactured by BYK-Chemie). Furthermore, compounds having the following structure can also be used as the silicone surfactant.

[0182] The content of the surfactant in the total solid content of the curable composition is preferably 0.001% by mass to 5.0% by mass, more preferably 0.005% by mass to 3.0% by mass. The surfactant may be one type or two or more types. When two or more types are used, it is preferable that the total amount is in the above range.

[0183] <<Antioxidant>> The curable composition of the present invention may contain an antioxidant. Examples of the antioxidant include phenolic antioxidants, amine antioxidants, phosphorus-based antioxidants, and sulfur-based antioxidants. Examples of the phenolic antioxidant include hindered phenol compounds. The phenolic antioxidant is preferably a compound having a substituent at the position adjacent to the phenolic hydroxy group (ortho position). The substituent is preferably a substituted or unsubstituted alkyl group having 1 to 22 carbon atoms. The antioxidant is also preferably a compound having a phenol group and a phosphite ester group in the same molecule. Examples of phosphorus-based antioxidants include tris[2-[[2,4,8,10-tetrakis(1,1-dimethylethyl)dibenzo[d,f][1,3,2]dioxaphosphepin-6-yl]oxy]ethyl]amine, tris[2-[(4,6,9,11-tetra-tert-butyldibenzo[d,f][1,3,2]dioxaphosphepin-2-yl)oxy]ethyl]amine, ethyl bis(2,4-di-tert-butyl-6-methylphenyl)phosphite, and tris(2,4-di-tert-butylphenyl)phosphite. Commercially available antioxidants include, for example, ADK STAB AO-20, ADK STAB AO-30, ADK STAB AO-40, ADK STAB AO-50, ADK STAB AO-50F, ADK STAB AO-60, ADK STAB AO-60G, ADK STAB AO-80, ADK STAB AO-330 (manufactured by ADEKA Corporation), and JP-650 (manufactured by Johoku Chemical Industry Co., Ltd.). Antioxidants include the compounds described in paragraphs 0023 to 0048 of Japanese Patent No. 6268967, the compounds described in WO 2017 / 006600, the compounds described in WO 2017 / 164024, and the compounds described in Korean Patent Publication No. 10-2019-0059371. The content of the antioxidant in the total solid content of the curable composition is preferably 0.01 to 20 mass %, more preferably 0.3 to 15 mass %. Only one type of antioxidant may be used, or two or more types may be used. When two or more types are used, the total amount thereof is preferably within the above range.

[0184] <<Other Components>> The curable composition of the present invention may contain, as necessary, a sensitizer, a plasticizer, and other auxiliaries (e.g., conductive particles, fillers, antifoaming agents, flame retardants, leveling agents, release promoters, fragrances, surface tension modifiers, chain transfer agents, etc.). By appropriately incorporating these components, properties such as film properties can be adjusted. As these components, the compounds described in paragraph 0182 of WO 2022 / 085485 can be used.

[0185] The curable composition of the present invention may contain a metal oxide in order to adjust the refractive index of the resulting film. Examples of the metal oxide include TiO 2 , ZrO 2 , Al 2 O 3 , SiO 2 The primary particle size of the metal oxide is preferably 1 to 100 nm, more preferably 3 to 70 nm, and even more preferably 5 to 50 nm. The metal oxide may have a core-shell structure. In this case, the core may be hollow.

[0186] The curable composition of the present invention may contain a light resistance improver. Examples of the light resistance improver include the compounds described in paragraph 0183 of WO 2022 / 085485.

[0187] It is also preferable that the curable composition of the present invention is substantially free of terephthalic acid esters. Here, "substantially free" means that the content of terephthalic acid esters in the total amount of the curable composition is 1,000 ppb by mass or less, more preferably 100 ppb by mass or less, and particularly preferably zero.

[0188] In view of environmental regulations, the curable composition of the present invention preferably has a melamine content of 10,000 ppm by mass or less.

[0189] The curable composition of the present invention preferably has a free metal content of 100 ppm or less, more preferably 50 ppm or less. The free halogen content is preferably 100 ppm or less, more preferably 50 ppm or less. Methods for reducing the free metals and halogens in the curable composition include washing with ion-exchanged water, filtration, ultrafiltration, and purification with an ion-exchange resin.

[0190] From the viewpoint of environmental regulations, the use of perfluoroalkyl sulfonic acids and their salts, and perfluoroalkyl carboxylic acids and their salts may be restricted. When the content of the above-mentioned compounds in the curable composition of the present invention is reduced, the content of perfluoroalkyl sulfonic acids (particularly perfluoroalkyl sulfonic acids having a perfluoroalkyl group of 6 to 8 carbon atoms) and their salts, and perfluoroalkyl carboxylic acids (particularly perfluoroalkyl carboxylic acids having a perfluoroalkyl group of 6 to 8 carbon atoms) and their salts is preferably in the range of 0.01 ppb to 1,000 ppb, more preferably in the range of 0.05 ppb to 500 ppb, and even more preferably in the range of 0.1 ppb to 300 ppb, relative to the total solids content of the curable composition. The curable composition of the present invention may be substantially free of perfluoroalkyl sulfonic acids and their salts, and perfluoroalkyl carboxylic acids and their salts. For example, by using a compound that can replace perfluoroalkyl sulfonic acid and its salt, and a compound that can replace perfluoroalkyl carboxylic acid and its salt, a curable composition that is substantially free of perfluoroalkyl sulfonic acid and its salt, and perfluoroalkyl carboxylic acid and its salt may be selected. Examples of compounds that can replace restricted compounds include compounds that are exempt from restrictions due to differences in the number of carbon atoms in the perfluoroalkyl group. However, the above does not preclude the use of perfluoroalkyl sulfonic acid and its salt, and perfluoroalkyl carboxylic acid and its salt. The curable composition of the present invention may contain perfluoroalkyl sulfonic acid and its salt, and perfluoroalkyl carboxylic acid and its salt, within the maximum allowable range.

[0191] The water content of the curable composition of the present invention is usually 3% by mass or less, preferably 0.01 to 1.5% by mass, and more preferably 0.1 to 1.0% by mass. The water content can be measured by the Karl Fischer method.

[0192] The curable composition of the present invention can be used by adjusting the viscosity for the purpose of adjusting the film surface state (flatness, etc.), adjusting the film thickness, etc. The viscosity value can be appropriately selected as needed, but is preferably 0.3 mPa·s to 50 mPa·s, and more preferably 0.5 mPa·s to 20 mPa·s at 25°C. The viscosity can be measured, for example, using a cone-plate type viscometer with the temperature adjusted to 25°C.

[0193] <<Storage Container>> The container for storing the curable composition is not particularly limited, and any known container can be used. In addition, the container described in paragraph 0187 of WO 2022 / 085485 can be used as the storage container.

[0194] <Method for preparing curable composition> The curable composition of the present invention can be prepared by mixing the above-mentioned components. When preparing the curable composition, all components may be simultaneously dissolved and / or dispersed in a solvent to prepare the curable composition, or, if necessary, each component may be prepared as two or more appropriate solutions or dispersions, which are mixed at the time of use (application) to prepare the curable composition.

[0195] The preparation of the curable composition preferably includes a process for dispersing the pigment. In the process for dispersing the pigment, mechanical forces used to disperse the pigment include compression, squeezing, impact, shear, and cavitation. Specific examples of these processes include a bead mill, a sand mill, a roll mill, a ball mill, a paint shaker, a microfluidizer, a high-speed impeller, a sand grinder, a flow jet mixer, high-pressure wet atomization, and ultrasonic dispersion. Furthermore, when grinding the pigment in a sand mill (bead mill), it is preferable to use small-diameter beads, increase the bead packing ratio, or otherwise increase the grinding efficiency under such conditions. Furthermore, it is preferable to remove coarse particles after the grinding process by filtration, centrifugation, or the like. In addition, the process and disperser for dispersing pigments can be suitably used, for example, the process and disperser described in "Dispersion Technology Encyclopedia," published by Joho Kiko Co., Ltd., July 15, 2005, or "Dispersion Technology and Industrial Applications Focused on Suspension (Solid / Liquid Dispersion System) - Comprehensive Data Collection," published by the Management Development Center Publishing Department, October 10, 1978, and paragraph 0022 of JP 2015-157893 A. In addition, in the process for dispersing pigments, particle refinement may be performed in a salt milling process. For details on the materials, equipment, processing conditions, etc. used in the salt milling process, see, for example, JP 2015-194521 A and JP 2012-046629 A. Examples of materials for beads used in dispersion include zirconia, agate, quartz, titania, tungsten carbide, silicon nitride, alumina, stainless steel, and glass. The beads may also be made of an inorganic compound having a Mohs hardness of at least 2. The curable composition may contain 1 to 10,000 ppm of the beads.

[0196] When preparing the curable composition, it is preferable to filter the curable composition with a filter for the purpose of removing foreign matter, reducing defects, etc. Examples of the type of filter and filtration method used for filtration include the filters and filtration methods described in paragraphs 0196 to 0199 of WO 2022 / 085485.

[0197] <Film> The film of the present invention is a film obtained from the curable composition of the present invention described above. The film of the present invention can be used for optical filters such as color filters, near-infrared transmission filters, and near-infrared cut filters.

[0198] The thickness of the film of the present invention can be adjusted appropriately depending on the purpose. For example, the thickness is preferably 20 μm or less, more preferably 10 μm or less, and even more preferably 5 μm or less. The lower limit of the thickness is preferably 0.1 μm or more, more preferably 0.2 μm or more, and even more preferably 0.3 μm or more.

[0199] When the film of the present invention is used as a color filter, the film of the present invention preferably has a green, red, blue, cyan, magenta, or yellow hue, and more preferably has a red hue. Furthermore, the film of the present invention can be preferably used as a color pixel of a color filter. Examples of the color pixel include a red pixel, a green pixel, a blue pixel, a magenta pixel, a cyan pixel, and a yellow pixel, and a red pixel is more preferred.

[0200] <Pixel Manufacturing Method> A pixel manufacturing method using the curable composition of the present invention will be described. The pixel manufacturing method includes the steps of forming a curable composition layer on a support using the curable composition of the present invention, exposing the curable composition layer to light in a pattern, and developing and removing the unexposed areas of the curable composition layer. If necessary, a step of baking the curable composition layer (pre-baking step) and a step of baking the developed pattern (pixel) (post-baking step) may also be provided.

[0201] In the step of forming a curable composition layer, the curable composition layer is formed on a support using the curable composition of the present invention. The support is not particularly limited and can be appropriately selected depending on the application. Examples include a glass substrate and a silicon substrate, with a silicon substrate being preferred. The silicon substrate may also be formed with a charge-coupled device (CCD), a complementary metal-oxide semiconductor (CMOS), a transparent conductive film, or the like. A black matrix is ​​sometimes formed on the silicon substrate to isolate each pixel. The silicon substrate may also be provided with an underlayer to improve adhesion with an upper layer, prevent diffusion of substances, or flatten the substrate surface. The surface contact angle of the underlayer is preferably 20 to 70° when measured with diiodomethane. It is also preferably 30 to 80° when measured with water.

[0202] Known methods can be used as the coating method for the curable composition. For example, a dropping method (drop casting); a slit coating method; a spray method; a roll coating method; a rotary coating method (spin coating); a casting coating method; a slit and spin method; a pre-wetting method (for example, the method described in JP 2009-145395 A); inkjet (for example, on-demand method, piezo method, thermal method), various printing methods such as nozzle jet and other ejection printing, flexographic printing, screen printing, gravure printing, reverse offset printing, metal mask printing; a transfer method using a mold or the like; a nanoimprint method, etc. can also be mentioned. In addition, the coating method described in paragraph 0207 of WO 2022 / 085485 A can also be used.

[0203] The curable composition layer formed on the support may be dried (prebaked). When a film is produced by a low-temperature process, prebaking may not be performed. When prebaking is performed, the prebaking temperature is preferably 150°C or lower, more preferably 120°C or lower, and even more preferably 110°C or lower. The lower limit can be, for example, 50°C or higher, or can also be 80°C or higher. The prebaking time is preferably 10 to 300 seconds, more preferably 40 to 250 seconds, and even more preferably 80 to 220 seconds. Prebaking can be performed using a hot plate, an oven, or the like.

[0204] Next, the curable composition layer is exposed to light in a pattern (exposure step). For example, the curable composition layer can be exposed to light in a pattern by using a stepper exposure machine, a scanner exposure machine, or the like, through a mask having a predetermined mask pattern. This allows the exposed portion to be cured.

[0205] Examples of radiation (light) that can be used for exposure include g-line and i-line. Light with a wavelength of 150 to 300 nm can also be used. Examples of light with a wavelength of 150 to 300 nm include KrF line (wavelength 248 nm) and ArF line (wavelength 193 nm), with KrF line (wavelength 248 nm) being preferred. Light with a wavelength of 150 to 300 nm is preferably excimer laser light with a wavelength of 150 to 300 nm. A long-wavelength light source of 300 nm or more can also be used for exposure.

[0206] In the exposure step, the curable composition layer is preferably exposed in a pattern by irradiating it with light having a wavelength of 150 to 300 nm (preferably excimer laser light having a wavelength of 150 to 300 nm).

[0207] The exposure may be performed by continuous irradiation with light or by pulsed irradiation (pulse exposure), which is an exposure method in which light is repeatedly irradiated and paused in a short cycle (for example, on the order of milliseconds or less).

[0208] The irradiation amount (exposure amount) is, for example, 0.03 to 2.5 J / cm 2 is preferred, and 0.05 to 1.0 J / cm 2 The oxygen concentration during exposure can be appropriately selected. In addition to being performed in the atmosphere, exposure may be performed in a low-oxygen atmosphere with an oxygen concentration of 19% by volume or less (e.g., 15% by volume, 5% by volume, or substantially oxygen-free), or in a high-oxygen atmosphere with an oxygen concentration of more than 21% by volume (e.g., 22% by volume, 30% by volume, or 50% by volume). The exposure illuminance can be appropriately set, and is usually 1000 W / m 2 ~100000W / m 2 (For example, 5000 W / m 2 , 15000W / m2 , or 35,000 W / m 2 The oxygen concentration and exposure illuminance may be appropriately combined. For example, an oxygen concentration of 10% by volume and an illuminance of 10,000 W / m 2 , oxygen concentration 35% by volume, illuminance 20,000 W / m 2 etc.

[0209] Next, the unexposed portions of the curable composition layer are developed and removed to form a pattern (pixels). The unexposed portions of the curable composition layer can be developed and removed using a developer. As a result, the unexposed portions of the curable composition layer in the exposure step are dissolved into the developer, leaving only the photocured portions. The temperature of the developer is preferably, for example, 20 to 30°C. The development time is preferably 20 to 180 seconds. In addition, to improve residue removability, the process of shaking off the developer every 60 seconds and then supplying fresh developer may be repeated several times.

[0210] Examples of the developer include organic solvents and alkaline developers, and alkaline developers are preferably used. Regarding the developer and the washing (rinsing) method after development, the developer and washing method described in paragraph 0214 of WO 2022 / 085485 can be used.

[0211] After development and drying, it is preferable to perform additional exposure treatment or heating treatment (post-baking). The additional exposure treatment or post-baking is a post-development curing treatment to ensure complete curing. The heating temperature in post-baking is, for example, preferably 100 to 300°C, more preferably 200 to 270°C. Post-baking can be performed continuously or batchwise using a heating means such as a hot plate, convection oven (hot air circulation dryer), or high-frequency heater to achieve the above conditions for the developed film. When additional exposure treatment is performed, it is preferable that the light used for exposure has a wavelength of 400 nm or less. The additional exposure treatment may also be performed by the method described in Korean Patent Publication No. 10-2017-0122130.

[0212] <Optical Filter> The optical filter of the present invention has the above-described film of the present invention. Types of optical filters include color filters, near-infrared cut filters, and near-infrared transmission filters, and a color filter is preferred. The color filter preferably has the film of the present invention as its pixel, more preferably has the film of the present invention as its color pixel, and even more preferably has the film of the present invention as its red pixel.

[0213] The optical filter may have a protective layer provided on the surface of the film of the present invention. By providing a protective layer, various functions can be imparted, such as oxygen blocking, low reflectivity, hydrophilicity / hydrophobicity, and blocking of light of specific wavelengths (ultraviolet rays, near-infrared rays, etc.). The thickness of the protective layer is preferably 0.01 to 10 μm, more preferably 0.1 to 5 μm. Methods for forming the protective layer include a method of applying a resin composition for forming the protective layer, a chemical vapor deposition method, and a method of attaching a molded resin with an adhesive. Components constituting the protective layer include (meth)acrylic resin, ene-thiol resin, polycarbonate resin, polyether resin, polyarylate resin, polysulfone resin, polyethersulfone resin, polyphenylene resin, polyarylene ether phosphine oxide resin, polyimide resin, polyamideimide resin, polyolefin resin, cyclic olefin resin, polyester resin, styrene resin, polyol resin, polyvinylidene chloride resin, melamine resin, urethane resin, aramid resin, polyamide resin, alkyd resin, epoxy resin, modified silicone resin, fluororesin, polyacrylonitrile resin, cellulose resin, Si, C, W, Al 2 O 3 , Mo, SiO 2 , Si 2 N 4 For example, in the case of a protective layer intended to block oxygen, the protective layer may contain a polyol resin and SiO 2 and Si 2 N 4 In the case of a protective layer intended to reduce reflection, the protective layer preferably contains a (meth)acrylic resin and a fluorine resin.

[0214] When forming a protective layer by applying a resin composition, known methods such as spin coating, casting, screen printing, and inkjet printing can be used as the method for applying the resin composition. Known organic solvents (e.g., propylene glycol 1-monomethyl ether 2-acetate, cyclopentanone, ethyl lactate, etc.) can be used as the organic solvent contained in the resin composition. When forming the protective layer by chemical vapor deposition, known chemical vapor deposition methods (thermal chemical vapor deposition, plasma chemical vapor deposition, photochemical vapor deposition) can be used as the chemical vapor deposition method.

[0215] The protective layer may contain additives such as organic or inorganic fine particles, absorbers for light of specific wavelengths (e.g., ultraviolet light, near-infrared light, etc.), refractive index adjusters, antioxidants, adhesives, and surfactants, as needed. Examples of organic or inorganic fine particles include polymeric fine particles (e.g., silicone resin fine particles, polystyrene fine particles, melamine resin fine particles), titanium oxide, zinc oxide, zirconium oxide, indium oxide, aluminum oxide, titanium nitride, titanium oxynitride, magnesium fluoride, hollow silica, silica, calcium carbonate, and barium sulfate. Known absorbers for light of specific wavelengths can be used. The content of these additives can be adjusted as appropriate, but is preferably 0.1 to 70% by mass, and more preferably 1 to 60% by mass, of the total mass of the protective layer.

[0216] As the protective layer, the protective layers described in paragraphs 0073 to 0092 of JP-A-2017-151176 can also be used.

[0217] The optical filter may have a structure in which each pixel is embedded in a space partitioned by partition walls, for example, in a grid pattern.

[0218] <Solid-state imaging device> The solid-state imaging device of the present invention has the above-described film of the present invention. The configuration of the solid-state imaging device is not particularly limited as long as it has the film of the present invention and functions as a solid-state imaging device, but examples thereof include the following configurations.

[0219] The substrate includes a plurality of photodiodes constituting a light-receiving area of ​​a solid-state imaging device (such as a CCD (charge-coupled device) image sensor or a CMOS (complementary metal-oxide semiconductor) image sensor) and transfer electrodes made of polysilicon or the like. A light-shielding film is formed on the photodiodes and transfer electrodes, with only the light-receiving portions of the photodiodes exposed. A device protection film made of silicon nitride or the like is formed on the light-shielding film so as to cover the entire light-shielding film and the light-receiving portions of the photodiodes. A color filter is also provided on the device protection film. Furthermore, the device protection film may include a light-collecting means (e.g., a microlens, etc.; the same applies hereinafter) below the color filter (on the side closer to the substrate), or on the color filter. The color filter may have a structure in which each color pixel is embedded in a space partitioned by partition walls, for example, in a grid pattern. In this case, the partition walls preferably have a lower refractive index than the color pixels. Examples of imaging devices having such a structure include those described in JP 2012-227478 A, JP 2014-179577 A, and WO 2018 / 043654 A. Furthermore, as shown in JP 2019-211559 A, an ultraviolet absorbing layer may be provided within the structure of the solid-state imaging element to improve light resistance. An imaging device equipped with the solid-state imaging element of the present invention can be used for digital cameras, electronic devices with imaging functions (such as mobile phones), as well as in-vehicle cameras and surveillance cameras.

[0220] <Image Display Device> The image display device of the present invention has the above-described film of the present invention. Examples of image display devices include liquid crystal display devices and organic electroluminescence display devices. Definitions of image display devices and details of each image display device are described, for example, in "Electronic Display Devices" (written by Akio Sasaki, published by Kogyo Chosakai Co., Ltd. in 1990) and "Display Devices" (written by Nobuaki Ibuki, published by Sangyo Tosho Co., Ltd. in 1989). Liquid crystal display devices are described, for example, in "Next Generation Liquid Crystal Display Technology" (edited by Tatsuo Uchida, published by Kogyo Chosakai Co., Ltd. in 1994). There are no particular limitations on the liquid crystal display device to which the present invention can be applied, and the present invention can be applied to various types of liquid crystal display devices described in the above-mentioned "Next Generation Liquid Crystal Display Technology."

[0221] The present invention will be explained in more detail below with reference to examples. The materials, amounts used, ratios, treatment details, treatment procedures, etc. shown in the following examples can be changed as appropriate without departing from the spirit of the present invention. Therefore, the scope of the present invention is not limited to the specific examples shown below. In addition, in the structural formulas shown below, Et represents an ethyl group, and Ac represents an acetyl group.

[0222] <Synthesis Examples> (Synthesis Example 1) 14.1 g of compound (I), 17.5 g of compound (II), and 20.7 g of potassium carbonate were placed in a three-necked flask and dissolved in 200 mL of dimethylformamide (DMF). This was heated and stirred at 150°C for 6 hours. The resulting reaction solution was added dropwise to ice water, and the precipitated powder was collected by filtration. Purification was carried out by silica gel column chromatography (hexane / ethyl acetate = 6 / 1), yielding 23.7 g of compound A-16B.

[0223] 14.8 g of compound A-16B was dissolved in 200 mL of tetrahydrofuran (THF), and 8.5 g of hydroxylamine hydrochloride, 9.5 g of sodium acetate, and 50 mL of pure water were added. This was heated and stirred at 50°C for 4 hours. The resulting reaction solution was extracted with ethyl acetate and washed with water, and the organic layer was then concentrated to obtain 12.6 g of compound A-16A. The wavy line in the structural formula represents the E-form or the Z-form. NMR (nuclear magnetic resonance analysis) revealed that compound A-16A was a mixture of E-form and Z-form in a ratio of 95 / 5 (mass ratio). (E-isomer: NMR (deuterated DMSO (dimethyl sulfoxide))) 1.91 (m, 2H), 2.11 (t, 2H), 2.94 (t, 2H), 3.79 (s, 3H), 6.9-7.8 (m, 14H), 7.97 (s, 1H), 8.07 (d, 1H), 8.38 (d, 1H), 8.95 (d, 1H), 9.12 (d, 1H), 11.21 (brs, 1H) (Z form: NMR (heavy DMSO)) 1.91 (m, 2H), 2.11 (t, 2H), 2.92 (t, 2H), 3.79 (s, 3H), 6.9-7.8 (m, 14 H), 8.13 (s, 1H), 8.07 (d, 1H), 8.38 (d, 1H), 8.95 (d, 1H), 9.12 (d, 1H), 11.23 (brs, 1H)

[0224] 12.9 g of compound A-16A, a mixture of E and Z isomers (E / Z = 95 / 5), was dissolved in 100 mL of ethyl acetate and cooled to 5°C. 4.8 g of triethylamine (TEA) was added, and 3.5 g of acetyl chloride was slowly added dropwise over 10 minutes. The reaction solution was warmed to room temperature and stirred for an additional 2 hours. The solution was separated with purified water, and the organic layer was concentrated under reduced pressure. 30 mL of acetonitrile was added to the concentrate, which was then added dropwise to 200 mL of cold water for crystallization, yielding 10.5 g of compound A-16. The wavy line in the structural formula represents the geometric isomer of the E or Z isomer. NMR revealed that compound A-16 was a mixture of E and Z isomers in a ratio of 95 / 5 (mass ratio). (E form: NMR (heavy DMSO)) 1.91 (m, 2H), 2.11 (t, 2H), 2.33 (s, 3H), 2.94 (t, 2H), 3.79 (s, 3H) , 6.9-7.8 (m, 14H), 7.80 (s, 1H), 8.07 (d, 1H), 8.38 (d, 1H), 8.95 (d, 1H), 9.12 (d, 1H) (Z form: NMR (heavy DMSO)) 1.91 (m, 2H), 2.11 (t, 2H), 2.31 (s, 3H), 2.94 (t, 2H), 3.79 (s, 3H) , 6.9-7.8 (m, 14H), 8.01 (s, 1H), 8.07 (d, 1H), 8.38 (d, 1H), 8.95 (d, 1H), 9.12 (d, 1H)

[0225] 10.5 g of Compound A-16, a mixture of E- and Z-isomers, was separated by silica gel column chromatography (hexane / ethyl acetate / triethylamine=4 / 1 / 0.1) to obtain 6.9 g of Compound A-16E, the E-isomer, and 0.25 g of Compound A-16Z, the Z-isomer, each as a single compound. The Rf value of Compound A-16E was 0.35, and the Rf value of Compound A-16Z was 0.30.

[0226] Synthesis Example 2 Compound A-50 was obtained in the same manner as in Synthesis Example 1, except that compound (III) was used instead of compound (II). The wavy lines in the structural formula represent the geometric isomers of E or Z isomers. NMR revealed that compound A-50 was a mixture of E and Z isomers in a ratio of 93 / 7 (mass ratio). (E isomer: NMR (deuterated CHCl 3)) 1.19 (m, 2H), 1.55 (m, 2H), 1.64 (m, 2H), 1.72 (m, 2H), 1.86 (m, 2H), 1.91 (m, 1H), 2.33 (s, 3H), 2.86 (dd, 2H), 4 .09 (s, 3H), 6.83 (d, 1H), 7.33 (dd, 2H), 7.5-7.6 (m, 5H), 7.69 (s, 1H), 8.04 (d, 2H), 8.39 (td, 2H), 8.48 (dd, 1H) (Z-form: NMR (heavy CHCl 3 )) 1.19 (m, 2H), 1.55 (m, 2H), 1.64 (m, 2H), 1.72 (m, 2H), 1.86 (m, 2H), 1.91 (m, 1H), 2.30 (s, 3H), 2.82 (dd, 2H), 4 .09 (s, 3H), 6.83 (d, 1H), 7.33 (dd, 2H), 7.5-7.6 (m, 5H), 7.76 (s, 1H), 8.04 (d, 2H), 8.39 (td, 2H), 8.48 (dd, 1H))

[0227] 12.3 g of Compound A-50, which was a mixture of E- and Z-isomers, was separated by silica gel column chromatography (hexane / ethyl acetate / triethylamine=4 / 1 / 0.1) to obtain 6.2 g of Compound A-50E, which was the E-isomer, and 0.46 g of Compound A-50Z, which was the Z-isomer, each as a single compound. The Rf value of Compound A-50E was 0.30, and the Rf value of Compound A-50Z was 0.28.

[0228] Synthesis Example 3 Compound A-64 was obtained in the same manner as in Synthesis Example 1, except that compound (IV) was used instead of compound (I) and compound (V) was used instead of compound (II). The wavy lines in the structural formula represent the geometric isomers of E or Z isomers. NMR revealed that compound A-64 was a mixture of E and Z isomers in a ratio of 85 / 15 (mass ratio). (E isomer: NMR (deuterated CHCl 3)), 0.91 (d, 6H), 1.37 (t, 3H), 1.43 (m, 2H), 1.62 (m, 1H), 2.35 (s, 3H), 2.37 (s, 3H), 2.49 (s, 3H), 2.81 (dd, 2H), 4.30 (q, 2H), 7.2-7.6 (m, 13H), 7.73 (s, 1H), 8.49 (s, 1H), 8.74 (s, 1H), 8.48 (m, 2H) (Z-form: NMR (heavy CHCl 3 )) 0.91 (d, 6H), 1.37 (t, 3H), 1.43 (m, 2H), 1.62 (m, 1H), 2.34 (s, 3H), 2.37 (s, 3H), 2.51 (s, 3H), 2 .81 (dd, 2H), 4.30 (q, 2H), 7.2-7.6 (m, 13H), 7.81 (s, 1H), 8.49 (s, 1H), 8.74 (s, 1H), 8.48 (m, 2H)

[0229] 12.3 g of Compound A-64, a mixture of E- and Z-isomers, was separated by silica gel column chromatography (hexane / ethyl acetate / triethylamine=5 / 1 / 0.1) to obtain 7.1 g of Compound A-16E, the E-isomer, and 0.52 g of Compound A-16Z, the Z-isomer, each as a single compound. The Rf value of Compound A-64E was 0.20, and the Rf value of Compound A-64Z was 0.15.

[0230] <Preparation of Photopolymerization Initiators> (Preparation Example 1) Photopolymerization initiators A-16-1 to A-16-5 and A-16-C1 were each prepared by adjusting the ratio of compound A-16E and compound A-16Z. Compound A-16E and compound A-16Z each have the structure described above.

[0231] (Preparation Example 2) Photopolymerization initiators A-50-1 to A-50-5 and A-50-C1 were prepared by adjusting the ratio of compound A-50E and compound A-50Z. Compound A-50E and compound A-50Z each have the structure described above.

[0232] (Preparation Example 3) Photopolymerization initiators A-64-1 to A-64-5 and A-64-C1 were prepared by adjusting the ratio of compound A-64E and compound A-64Z. Compound A-64E and compound A-64Z each have the structure described above.

[0233] <Preparation of Dispersion> The materials listed in the table below were mixed to obtain a mixture. The obtained mixture was subjected to a dispersion treatment using an Ultra Apex Mill manufactured by Kotobuki Industries Co., Ltd. as a circulating dispersion device (bead mill) to produce a dispersion. The numerical values ​​of the amounts added in the table are in parts by mass.

[0234]

[0235] Details of the materials listed in the table above are as follows:

[0236] (Pigment) PG7: C.I. Pigment Green 7 (green pigment) PG36: C.I. Pigment Green 36 (green pigment) PG58: C.I. Pigment Green 58 (green pigment) PG59: C.I. Pigment Green 59 (green pigment) PY129: C.I. Pigment Yellow 129 (yellow pigment) PY138: C.I. Pigment Yellow 138 (yellow pigment) PY139: C.I. Pigment Yellow 139 (yellow pigment) PY150: C.I. Pigment Yellow 150 (yellow pigment) PY185: C.I. Pigment Yellow 185 (yellow pigment) PR177: C.I. Pigment Red 177 (red pigment) PR254: C.I. Pigment Red 254 (red pigment) PR264: C.I. Pigment Red 264 (red pigment) PR272: C.I. Pigment Red 272 (red pigment) PR291: C.I. Pigment Red 291 (red pigment) PB15:3: C.I. Pigment Blue 15:3 (blue pigment) PB15:4: C.I. Pigment Blue 15:4 (blue pigment) PB15:6: C.I. Pigment Blue 15:6 (blue pigment) PB16: C.I. Pigment Blue 16 (blue pigment) PV23: C.I. Pigment Violet 23 (purple pigment) P-23: Compound having the following structure (pyrrolopyrrole compound, near-infrared absorbing pigment) P-24: Compound having the following structure (squarylium compound, near-infrared absorbing pigment)

[0237] (Dispersing aid) Syn-1: Compound having the following structure (pigment derivative) Syn-2: polyethyleneimine (Epomin SP-006 (manufactured by Nippon Shokubai Co., Ltd.)) Syn-3: compound having the following structure (pigment derivative) Syn-4: Compound having the following structure (pigment derivative) Syn-5: Compound having the following structure (pigment derivative) Syn-6: Compound having the following structure (pigment derivative) Syn-7: Compound having the following structure (pigment derivative) Syn-8: Compound having the following structure (pigment derivative)

[0238] (Resin) B-1: Resin having the following structure (the number attached to the main chain is the molar ratio, and the number attached to the side chain is the number of repeating units. Weight average molecular weight: 20,000, acid value: 66.6 mgKOH / g) B-2: Resin having the following structure (the number attached to the main chain is the molar ratio, and the number attached to the side chain is the number of repeating units. Weight average molecular weight: 23,000, acid value: 59.6 mgKOH / g) B-3: Resin having the following structure (the number attached to the main chain is the molar ratio, and the number attached to the side chain is the number of repeating units. Weight average molecular weight: 16,000, acid value: 67 mgKOH / g) B-4: Resin having the following structure (weight average molecular weight 18,000, acid value 82.1 mgKOH / g)

[0239] (Solvent) D-1: Propylene glycol monomethyl ether acetate

[0240] <Preparation of curable compositions> Curable compositions were prepared by mixing the types of dispersions, polymerizable compounds, resins, photopolymerization initiators, surfactants, polymerization inhibitors, chain transfer agents, and solvents shown in the table below. The units of the amounts added in the table are parts by mass.

[0241]

[0242]

[0243] Details of the materials listed in the table above are as follows:

[0244] (Dispersions) G Dispersions 1 to 4: G Dispersions 1 to 4 described above Y Dispersions 1 to 5: Y Dispersions 1 to 5 described above R Dispersions 1 to 6: R Dispersions 1 to 6 described above B Dispersions 1 to 4: B Dispersions 1 to 4 described above V Dispersion 1: V Dispersion 1 described above IR Dispersions 1, 2: IR Dispersions 1, 2 described above

[0245] (Polymerizable Compound) M-1: A mixture of compounds having the following structure (compound on the left: compound on the right = 7:3 (molar ratio), radical polymerizable compound) M-2: Compound having the following structure (radical polymerizable compound) M-3: Compound having the following structure (radical polymerizable compound) M-4: Compound having the following structure (radical polymerizable compound)

[0246] (Resin) C-1: Resin having the following structure (the numerical values ​​attached to the main chain are molar ratios; weight average molecular weight: 11,000; acid value: 69.2 mgKOH / g) C-2: Resin having the following structure (the numbers attached to the main chain are molar ratios; weight-average molecular weight: 21,000; acid value: 80 mg KOH / g)

[0247] (Photopolymerization initiator) A-16: the above-mentioned compound A-16 (ratio of E isomer to Z isomer is 95 / 5 (mass ratio)) A-16-1 to A-16-5, A-16-C1: the above-mentioned photopolymerization initiators A-16-1 to A-16-5, A-16-C1 A-50: the above-mentioned compound A-50 (ratio of E isomer to Z isomer is 93 / 7 (mass ratio)) A-50-1 to A-50-5, A-50-C1: the above-mentioned photopolymerization initiators A-50-1 to A-50-5, A-50-C1 A-64: the above-mentioned compound A-64 (ratio of E isomer to Z isomer is 85 / 15 (mass ratio)) A-64-1 to A-64-5, A-64-C1: the above-mentioned photopolymerization initiators A-64-1 to A-64-5, A-64-C1 CA-1: Compound having the following structure (E-isomer only) CA-2: Compound having the following structure (ratio of E-form to Z-form is 75 / 25 (mass ratio); the wavy line in the formula represents the geometric isomer of E-form or Z-form)

[0248] (Surfactant) W-1: KF-6000 (manufactured by Shin-Etsu Chemical Co., Ltd., silicone surfactant)

[0249] (Polymerization inhibitor) Q-1: p-methoxyphenol

[0250] (Chain transfer agents) S-1 to S-4: Compounds having the following structures (multifunctional thiol compounds)

[0251] (Solvent) D-1: Propylene glycol monomethyl ether acetate

[0252] <Evaluation> (Evaluation of storage stability) Each curable composition was placed in a sealed container and stored at 5°C for 30 days. After storage, the curable composition was applied to a glass substrate by spin coating, and then heated at 100°C for 2 minutes using a hot plate to obtain a curable composition layer. The obtained curable composition layer was then irradiated with 500 mJ / cm using an i-line stepper. 2 The resulting film was observed under an optical microscope to calculate the number of foreign matter defects that occurred within an area of ​​100 μm×100 μm, and the storage stability was evaluated according to the following criteria: A: 0 foreign matter defects B: 1 or more but less than 5 foreign matter defects C: 5 or more but less than 10 foreign matter defects D: 10 or more but less than 20 foreign matter defects E: 30 or more foreign matter defects

[0253] (Evaluation of Color Unevenness) A base coater (CT-4000, manufactured by FUJIFILM Electronic Materials Co., Ltd.) was applied to a glass substrate by spin coating so as to give a film thickness of 0.1 μm, and the substrate was heated at 220° C. for 1 hour using a hot plate to form a base layer. Each curable composition was applied to the glass substrate with the base layer by spin coating, and then heated at 100° C. for 2 minutes using a hot plate to obtain a curable composition layer with a thickness of 0.5 μm. This curable composition layer was exposed to light (KrF rays) with a wavelength of 248 nm through a mask having a 0.5 μm square pattern using a KrF scanner exposure machine at an illuminance of 35,000 W / m 2 , exposure dose 20 to 200 mJ / cm 2The film was then exposed to light at 1000 Hz. The film was then post-baked at 220°C for 300 seconds using a hot plate to form a film. The luminance distribution of the glass substrate (evaluation substrate) on which the film was formed was analyzed using the following method, and color unevenness was evaluated based on the number of pixels whose deviation from the average was ±10% or more. The luminance distribution measurement method is described below. The evaluation substrate was placed between the observation lens and light source of an optical microscope, and light was irradiated toward the observation lens. The transmitted light state was observed using an optical microscope MX-50 (manufactured by Olympus Corporation) equipped with a digital camera. Five arbitrarily selected regions of the film surface were photographed. The luminance of the photographed images was quantified as a density distribution of 256 gradations from 0 to 255 and saved. The luminance distribution of this image was analyzed, and color unevenness was evaluated based on the number of pixels whose deviation from the average exceeded ±10%. The evaluation criteria are as follows: A: The number of pixels whose deviation from the average exceeded ±10% was 1,000 or less. B: The number of pixels that deviate more than ±10% from the average is more than 1000 and less than 3000. C: The number of pixels that deviate more than ±10% from the average is more than 3000 and less than 5000. D: The number of pixels that deviate more than ±10% from the average is more than 5000 and less than 15000. E: The number of pixels that deviate more than ±10% from the average is more than 15000.

[0254] (Evaluation of Exposure Margin) An undercoat (CT-4000, manufactured by FUJIFILM Electronic Materials Co., Ltd.) was applied to an 8-inch (203.2 mm) silicon wafer by spin coating to a film thickness of 0.1 μm, and heated using a hot plate at 220° C. for 1 hour to form an undercoat layer. Each curable composition was applied to the glass substrate with the undercoat layer by spin coating, and then heated using a hot plate at 100° C. for 2 minutes to obtain a curable composition layer with a thickness of 0.4 μm. This curable composition layer was exposed to light (KrF rays) with a wavelength of 248 nm through a mask having a 0.5 μm square pattern using a KrF scanner exposure machine at an illuminance of 35,000 W / m 2 , exposure dose 20 to 200 mJ / cm 2The curable composition layer was exposed to light at 1000 W. Next, the exposed layer was subjected to shower development at 23°C for 60 seconds using a 0.3% by mass aqueous solution of tetramethylammonium hydroxide (TMAH) as a developer. The layer was then rinsed with pure water by spin shower to form pixels. The resulting pixels were observed at a magnification of 20,000x using a scanning electron microscope (S-4800H, manufactured by Hitachi High-Tech Corporation). A graph of the line width and exposure dose of the observed image (vertical axis: pixel line width (unit: μm), horizontal axis: exposure dose (unit: mJ)) was prepared, and the slope of the graph at a pixel line width of 0.7 μm (Δμm / ΔmJ = change in pixel line width relative to change in exposure dose (unit: μm / mJ)) was calculated. A: The slope of the graph (the amount of change in pixel line width with respect to the amount of change in exposure dose (unit: μm / mJ)) is less than 0.0010. B: The slope of the graph (the amount of change in pixel line width with respect to the amount of change in exposure dose (unit: μm / mJ)) is 0.0010 or more and less than 0.0012. C: The slope of the graph (the amount of change in pixel line width with respect to the amount of change in exposure dose (unit: μm / mJ)) is 0.0012 or more and less than 0.0015. D: The slope of the graph (the amount of change in pixel line width with respect to the amount of change in exposure dose (unit: μm / mJ)) is 0.0015 or more and less than 0.0020. E: The slope of the graph (the amount of change in pixel line width with respect to the amount of change in exposure dose (unit: μm / mJ)) is 0.0020 or more.

[0255]

[0256]

[0257] As shown in the table above, the Examples were excellent in the evaluation of storage stability and exposure margin. Furthermore, they were also excellent in the evaluation of color unevenness. Examples 14 to 17, which used a chain transfer agent, were particularly excellent in exposure sensitivity to KrF radiation.

Claims

1. A curable composition comprising a photopolymerization initiator and a radically polymerizable compound, wherein the photopolymerization initiator comprises an E-isomer of a compound represented by formula (1) and a Z-isomer of a compound represented by formula (1), and the content of the E-isomer relative to the total mass of the E-isomer and the Z-isomer is 80 to 99.9% by mass; In formula (1), R 1 represents an alkyl group, an aryl group, a heteroaryl group, an alkoxy group, an aryloxy group, or a heteroaryloxy group; R 2 represents an alkyl group, an aryl group, or a heteroaryl group; R 3 ~R 7 each independently represents a hydrogen atom, a halogen atom, a nitro group, or a monovalent organic group; R 4 ~R 7 Adjacent groups among R may be bonded to each other to form a ring; 101 represents a hydrogen atom or a monovalent organic group, n represents 0 or 1, and the wavy line represents an E or Z geometric isomer.

2. R in the above formula (1) 101 represents a hydrogen atom, an alkyl group, or a group represented by formula (R-101); In formula (R-101), * represents a bond, 1 represents an aromatic ring group or a heterocyclic group; R 11 represents an alkyl group, an aryl group, a heteroaryl group, an alkoxy group, an alkylthio group, an alkylamino group, an aryloxy group, an arylthio group, an arylamino group, a heteroaryloxy group, a heteroarylthio group, a heteroarylamino group, a cyano group, a nitro group, a hydroxy group, a carboxy group, a halogen atom, or a group represented by formula (R-1), m represents an integer of 0 to 5; In formula (R-1), Ar 2 represents an aromatic ring group or a heterocyclic group, 2 The aromatic ring group or heterocyclic group represented by the formula (I) may have at least one substituent selected from an alkyl group, an aryl group, a heteroaryl group, an alkoxy group, an alkylthio group, an alkylamino group, an aryloxy group, an arylthio group, an arylamino group, a heteroaryloxy group, a heteroarylthio group, a heteroarylamino group, a cyano group, a nitro group, a hydroxy group, a carboxy group, a halogen atom, and an acyl group.

3. Ar in the above formula (R-1) 2 The curable composition according to claim 2, wherein is a group represented by any one of formulas (Ar-1) to (Ar-17): In the formula, * represents a bond, R a1 ~R a15 each independently represents an alkyl group, an aryl group, a heteroaryl group, an alkoxy group, an alkylthio group, an alkylamino group, an aryloxy group, an arylthio group, an arylamino group, a heteroaryloxy group, a heteroarylthio group, a heteroarylamino group, a cyano group, a nitro group, a hydroxy group, a carboxy group, a halogen atom, or an acyl group; R ar1 ~R ar9 each independently represents a hydrogen atom or a monovalent organic group; k1 to k15 each independently represent an integer of 0 to 4.

4. R in the above formula (1) 2 The curable composition according to claim 1 or 2, wherein R is a group represented by formula (R-2): In formula (R-2), * represents a bond; 21 represents a single bond or an alkylene group having 1 to 6 carbon atoms; R 21 and R 22 each independently represents an alkyl group having 1 to 4 carbon atoms; R 21 and R 21 may be bonded to each other to form a ring.

5. R in the above formula (1) 2 The curable composition according to claim 1 or 2, wherein R is a group represented by formula (R-2a): In formula (R-2a), * represents a bond; 31 and R 32 each independently represents a hydrogen atom or a monovalent organic group; 31 represents a single bond or an alkylene group having 1 to 6 carbon atoms; 32 is -(CR L1 R L2 ) p - represents R L1 and R L2 each independently represents a hydrogen atom or a monovalent organic group, and p represents an integer of 1 to 4.

6. The curable composition according to claim 1 or 2, further comprising a coloring material.

7. The curable composition according to claim 1 or 2, comprising a chain transfer agent.

8. The curable composition according to claim 1 or 2, which is for exposure to light having a wavelength of 150 nm to 300 nm.

9. A method for manufacturing a pixel, comprising the steps of: forming a curable composition layer on a support using the curable composition according to claim 1 or 2; exposing the curable composition layer in a pattern by irradiating it with light having a wavelength of 150 nm to 300 nm; and developing and removing the unexposed areas of the curable composition layer.

10. A film obtained by curing the curable composition according to claim 1 or 2.

11. An optical filter comprising the film of claim 10.

12. A solid-state imaging device comprising the film according to claim 10.

13. An image display device comprising the film according to claim 10.

Citation Information

Patent Citations

  • Oxime ester compound and photopolymerization initiator containing said compound

    WO2015152153A1

  • Radical polymerization initiator, composition, cured product, and cured product manufacturing method

    WO2021200815A1